mitomycin has been researched along with Carcinoma, Hepatocellular in 373 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 9.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
| "It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma." | 9.14 | Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. ( Borner, M; Candinas, D; Dufour, JF; Heim, MH; Helbling, B; Hoppe, H; Kickuth, R; Maurhofer, O; Saar, B; Szucs-Farkas, Z, 2010) |
| "To observe the effect of postoperative transcatheter hepatic arterial chemoembolization (TACE) and thymosin alpha(1) (T(alpha1)) treatment on recurrence of hepatocellular carcinoma (HCC)." | 9.11 | [Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma]. ( Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX, 2004) |
| "To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and miriplatin (MPT) for hepatocellular carcinoma (HCC)." | 7.78 | Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. ( Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M, 2012) |
| "Wild-type RASSF1A inhibits cell growth and enhances cell chemosensitivity to mitomycin in hepatocellular carcinoma, suggesting that RASSF1A may serve as a new target for gene therapy in hepatocellular carcinoma patients." | 7.75 | RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells. ( Guan, HG; Lan, J; Qian, HX; Qin, L; Xue, WJ; Zhou, XJ, 2009) |
| "To determine the incidence of nausea and vomiting and the antiemetic effect of ondansetron hydrochloride (OND) in patients with hepatocellular carcinoma treated with arterial chemo-embolization, we studied 59 patients with hepatocellular carcinoma who were treated with transcatheter arterial embolization (TAE) or lipiodolized transcatheter arterial infusion (L-TAI)." | 7.70 | Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. ( Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H, 1999) |
| "In order to assess the efficacy of repeated hepatic arterial infusion (HAI) therapy for advanced hepatocellular carcinoma, we administered HAI therapy using 5-fluorouracil, epirubicin and mitomycin C, with an implanted drug delivery system." | 7.70 | Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. ( Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H, 1999) |
| "The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 7.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
| "Seventy five patients with nodular type of hepatocellular carcinoma (HCC) non-occluding the main portal vein were divided into the following groups and were compared for the prognosis: (I) administered intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate (DBcAMP) and mitomycin C (MMC) (n = 13); (II) treated with transcatheter arterial embolization (TAE) (n = 62)." | 7.69 | [Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization]. ( Sugimoto, M, 1994) |
| "One hundred thirty-five patients with hepatocellular carcinoma (HCC) were treated by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone (59 cases) and ADMOS plus cis-diaminodichloroplatinum (CDDP) (76 cases)." | 7.68 | [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum]. ( Fukukura, Y; Hokotate, H; Hori, A; Ida, K; Ikeda, K; Inoue, H; Kanetsuki, I; Miyazono, N; Tanaka, D; Tsuchimochi, S, 1993) |
| "We evaluated the effects of intraarterial injection of Adriamycin/Mitomycin C oil (Lipiodol) suspension (ADMOS) alone and ADMOS+cis-diaminodichloroplatinum (CDDP) in 135 patients with hepatocellular carcinoma (HCC)." | 7.68 | Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP). ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Miyake, S; Miyazono, N; Nakajo, M; Nishida, H; Satake, M, 1993) |
| "Of 210 patients with hepatocellular carcinoma (n = 135), metastatic liver cancer (n = 71) and cholangiocarcinoma (n = 4) who underwent intra-arterial infusion of adriamycin and/or mitomycin C oil suspension (ADMOS) and cisplatin, and both regimens, pyogenic liver abscess occurred in seven (3." | 7.68 | [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)]. ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Kobayashi, H; Nakajo, M; Nishida, H; Satake, M; Ueno, K, 1992) |
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 7.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 8 patients with hepatocellular carcinoma occluding the main portal vein." | 7.67 | Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies. ( Ishii, K; Karube, H; Okabe, H; Okudaira, M; Shibata, H; Tsuchiya, M, 1989) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 7.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| "Of 66 patients with hepatocellular carcinoma, 32 were treated by intraarterial injection of mitomycin C microcapsules (group A) and 34 patients by intraarterial injection of mitomycin C microcapsules followed by transcatheter hepatic artery embolization (group B)." | 7.67 | Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma. ( Iida, S; Nomura, F; Ohnishi, K; Sugita, S; Tanabe, Y, 1987) |
| "An intra-arterial injection of an Adriamycin-Lipiodol emulsion and a Mitomycin C microcapsule has been given to two patients of hepatocellular carcinoma (HCC) complicated with a tumor thrombosis of the portal trunk." | 7.67 | [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis]. ( Abe, T; Iizuka, H; Katakai, S; Nagamine, T; Ojima, T; Saitoh, S; Takagi, H; Takayama, H; Takezawa, J; Uehara, M, 1988) |
| "An analysis is done of 40 evaluable patients treated with a combination of 5-Fluorouracil, adriamycin and mitomycin-C for primary hepatocellular carcinoma in Saudi Arabia." | 7.67 | Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. ( Abdel Satir, A; Al-Idrissi, HY; Al-Kasem, S; Al-Qurain, A; Ibrahim, EM; Satti, MB, 1985) |
| "Four patients with advanced hepatocellular carcinoma, but with stage I functional disease, were treated with intrahepatic arterial lipoidal mixed with small doses of Adriamycin (20 mg) and Mitomycin C (10 mg)." | 7.67 | Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C. ( Chin, JH; Oon, CJ; Tan, L; Yong, YM, 1986) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 7.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "Twenty elderly patients with hepatocellular carcinoma were treated with 5-fluorouracil (5-FU) at a daily dose of 200-300 mg per os, and with a combination of 0." | 7.66 | [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil]. ( Asano, K; Ejiri, T; Fujii, M; Matsuka, Y; Murakami, N, 1982) |
| "20 patients had Barcelona Clinic Liver Cancer (BCLC) stage B, while 8 patients obtained chemoembolization for bridging purposes (BCLC stage A)." | 5.48 | Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients. ( Beeres, M; Eichler, K; Gruber-Rouh, T; Kamal, A; Langenbach, M; Naguib, NN; Vogl, TJ, 2018) |
| "Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered to be poor." | 5.33 | [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C]. ( Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS, 2005) |
| "A 64-year-old male was admitted for treatment of hepatocellular carcinoma." | 5.28 | [A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C]. ( Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N, 1992) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 5.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "Hepatocellular carcinoma is the most common cause of cancer death in Thai males." | 5.28 | High-dose mitomycin C: activity in hepatocellular carcinoma. ( Auethaveekiat, V; Cheirsilpa, A; Kangsumrit, N; Leelasethakul, S; Maoleekulpriroj, S; Phanthumjida, P; Thanakaravit, P, 1989) |
| "Of 20 patients with inoperable hepatocellular carcinoma (HCC) treated with one or more courses via a hepatic arterial catheter, a change in tumor size could be measured in 16." | 5.27 | Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. ( Goto, N; Hiyama, Y; Iwama, S; Kono, K; Nakajima, Y; Nakayama, T; Ohnishi, K; Ohtsuki, T; Takashi, M; Tsuchiya, S, 1984) |
| " Because previous studies showed that long-term telbivudine treatment improved renal function in chronic hepatitis B virus (HBV) infected patients, we conducted a case-control study to evaluate the clinical outcome of telbivudine preemptive therapy in HBV-related advanced HCC patients treated by combination chemotherapy comprising 5-fluorouracil, mitoxantrone and cisplatin (FMP)." | 5.19 | Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study. ( Chang, ML; Chen, YC; Chien, RN; Hsu, CW; Lin, CL; Yeh, C; Yeh, CT, 2014) |
| "To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 5.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
| "It is unknown whether sorafenib can be combined with transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma." | 5.14 | Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study. ( Borner, M; Candinas, D; Dufour, JF; Heim, MH; Helbling, B; Hoppe, H; Kickuth, R; Maurhofer, O; Saar, B; Szucs-Farkas, Z, 2010) |
| "To observe the effect of postoperative transcatheter hepatic arterial chemoembolization (TACE) and thymosin alpha(1) (T(alpha1)) treatment on recurrence of hepatocellular carcinoma (HCC)." | 5.11 | [Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma]. ( Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX, 2004) |
| "A total of 135 patients with hepatocellular carcinoma (HCC) were treated by intra-arterial injection of an Adriamycin/mitomycin C oil (lipiodol) suspension (ADMOS) alone or of ADMOS plus cis-diammine-dichloroplatinum (CDDP)." | 5.07 | Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection. ( Ikeda, K; Inoue, H; Kobayashi, H; Nakajo, M; Yano, T, 1992) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Previously, a pilot genome-wide association study has identified candidate single nucleotide polymorphism predictors for the therapeutic response of 5-fluorouracil, mitoxantrone and cisplatin (FMP) combination chemotherapy in advanced hepatocellular carcinoma (HCC)." | 3.80 | A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. ( Chang, ML; Hsu, CL; Hung, CF; Liang, KH; Lin, CC; Yeh, CT, 2014) |
| "The aim of the present study was to compare clinical outcomes in patients with intermediate-stage hepatocellular carcinoma (HCC) who underwent the following treatments: transcatheter arterial chemoembolization (TACE) using an epirubicin-mitomycin-lipiodol (EML) emulsion at initial therapy (TACE group; n=145), and transcatheter chemotherapy infusion (TACI) using an EML emulsion at initial therapy (TACI group; n=81)." | 3.80 | Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. ( Kimura, T; Kita, R; Komekado, H; Nasu, A; Nishiguchi, S; Nishijima, N; Nishikawa, H; Ohara, Y; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H, 2014) |
| "To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and miriplatin (MPT) for hepatocellular carcinoma (HCC)." | 3.78 | Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. ( Hashimoto, M; Matsui, O; Miyayama, S; Shibata, Y; Toshima, F; Tsuji, K; Yamashiro, M; Yoshida, M, 2012) |
| "The aim of the present study was to elucidate the effectiveness of transcatheter arterial infusion chemotherapy (TAI) of the whole liver using an epirubicin-mitomycin-lipiodol emulsion, prior to radiofrequency thermal ablation (RFA), in preventing intrahepatic distant recurrence (IDR) from single hepatocellular carcinoma (HCC)." | 3.78 | Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. ( Hatamaru, K; Henmi, S; Inuzuka, T; Kimura, T; Kita, R; Matsuda, F; Nakajima, J; Nasu, A; Nishikawa, H; Osaki, Y; Saito, S; Sakamoto, A; Takeda, H, 2012) |
| "Wild-type RASSF1A inhibits cell growth and enhances cell chemosensitivity to mitomycin in hepatocellular carcinoma, suggesting that RASSF1A may serve as a new target for gene therapy in hepatocellular carcinoma patients." | 3.75 | RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells. ( Guan, HG; Lan, J; Qian, HX; Qin, L; Xue, WJ; Zhou, XJ, 2009) |
| "The objective of our study was to describe survival outcome in 124 patients with unresectable hepatocellular carcinoma treated with triple-drug transcatheter arterial chemoembolization (TACE) using doxorubicin, cisplatin, and mitomycin C using a standardized regimen." | 3.75 | Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients. ( Amado, RG; Busuttil, RW; Gomes, AS; Monteleone, PA; Rosen, PJ; Rosove, MH; Sayre, JW, 2009) |
| "Between 1990 and 1997, 227 patients with hepatocellular carcinoma were treated by intrahepatic arterial injection of a Lipiodol-Epirubicin-Mitomycin C emulsion followed by intermittent hepatic artery infusion of Epirubicin, Mitomycin C and 5-FU, employing an implantable subcutaneous infusion port." | 3.70 | [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma]. ( An, M; Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takagi, S; Terakado, H; Watanabe, K, 1998) |
| "To determine the incidence of nausea and vomiting and the antiemetic effect of ondansetron hydrochloride (OND) in patients with hepatocellular carcinoma treated with arterial chemo-embolization, we studied 59 patients with hepatocellular carcinoma who were treated with transcatheter arterial embolization (TAE) or lipiodolized transcatheter arterial infusion (L-TAI)." | 3.70 | Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. ( Abe, T; Hashimoto, Y; Kojima, A; Mori, M; Nagamine, T; Sohara, N; Takagi, H; Takahashi, H, 1999) |
| "In order to assess the efficacy of repeated hepatic arterial infusion (HAI) therapy for advanced hepatocellular carcinoma, we administered HAI therapy using 5-fluorouracil, epirubicin and mitomycin C, with an implanted drug delivery system." | 3.70 | Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C. ( Chiba, T; Ito, K; Kojima, K; Nakajima, N; Seno, H, 1999) |
| "The co-incubation of morin hydrate with either doxorubicin or mitomycin C could minimize the toxicity of these anti-tumor drugs on cardiovascular cells, such as red blood cells, human umbilical vein endothelial cells (ECV304) and primary mouse cardiomyocytes, whereas morin hydrate did not lower the cytotoxicity of the drugs on human hepatocellular carcinoma cells (HepG2)." | 3.70 | Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. ( Chan, HC; Fung, KP; Kok, LD; Kwok, TT; Wong, YP; Wu, TW, 2000) |
| "The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 3.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
| "Bifunctional antibody (BFA) HC-1 possessing one binding site for mitomycin C (MMC) and a companion site directed against human hepatocellular carcinoma (HCC) cell membrane was constructed by chemical conjugation of two Fab' fragments of McAb MMC-1 and McAb HCMP-1." | 3.69 | [Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C]. ( Liu, KD; Tang, ZY; Wei, C, 1994) |
| "Seventy five patients with nodular type of hepatocellular carcinoma (HCC) non-occluding the main portal vein were divided into the following groups and were compared for the prognosis: (I) administered intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate (DBcAMP) and mitomycin C (MMC) (n = 13); (II) treated with transcatheter arterial embolization (TAE) (n = 62)." | 3.69 | [Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization]. ( Sugimoto, M, 1994) |
| "In this study, norcantharidin was compared with adriamycin and mitomycin C for its inhibitory action in the growth of cultured human hepatocellular carcinoma HepG2 cells." | 3.69 | Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. ( Cheng, LY; Mack, PO; Tang, WY; Yang, EB; Zhang, K, 1997) |
| "One hundred thirty-five patients with hepatocellular carcinoma (HCC) were treated by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone (59 cases) and ADMOS plus cis-diaminodichloroplatinum (CDDP) (76 cases)." | 3.68 | [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum]. ( Fukukura, Y; Hokotate, H; Hori, A; Ida, K; Ikeda, K; Inoue, H; Kanetsuki, I; Miyazono, N; Tanaka, D; Tsuchimochi, S, 1993) |
| "We evaluated the effects of intraarterial injection of Adriamycin/Mitomycin C oil (Lipiodol) suspension (ADMOS) alone and ADMOS+cis-diaminodichloroplatinum (CDDP) in 135 patients with hepatocellular carcinoma (HCC)." | 3.68 | Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP). ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Miyake, S; Miyazono, N; Nakajo, M; Nishida, H; Satake, M, 1993) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 27 patients with hepatocellular carcinoma (HCC) occluding the main portal vein." | 3.68 | Is necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC. ( Ishii, K; Kusano, S; Matama, S; Matsuki, S; Shibata, H; Sugimoto, M, 1992) |
| "Dibutyryl cyclic AMP was administered to 7 cases with hepatocellular carcinoma and its tumor thrombosis in portal vein, combined with intraarterial infusion of Mitomycin C or Adriamycin with implanted reservoir." | 3.68 | [Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis]. ( Fukui, H; Kitagami, K; Matsumoto, M; Nakano, H; Nakayama, M; Okamoto, Y; Tsujii, T, 1992) |
| "Of 210 patients with hepatocellular carcinoma (n = 135), metastatic liver cancer (n = 71) and cholangiocarcinoma (n = 4) who underwent intra-arterial infusion of adriamycin and/or mitomycin C oil suspension (ADMOS) and cisplatin, and both regimens, pyogenic liver abscess occurred in seven (3." | 3.68 | [Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)]. ( Hori, A; Ikeda, K; Inoue, H; Kanetsuki, I; Kobayashi, H; Nakajo, M; Nishida, H; Satake, M; Ueno, K, 1992) |
| "The concentration of adriamycin (ADR) and mitomycin C (MMC) were measured in serum and dialysate in a patient with hepatocellular carcinoma complicating chronic renal failure." | 3.68 | [A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis]. ( Chiba, S; Goto, T; Katayama, S; Kondoh, K; Moriai, O; Nakamura, Y; Ohsawa, K; Sasaki, S; Sekine, K; Yoshida, T, 1990) |
| "1-Hexylcarbamoyl-5-fluorouracil (HCFU) was orally administered at doses of 300-600 mg daily for 7-360 days to 27 inoperable cirrhotics with hepatocellular carcinoma." | 3.67 | [Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma]. ( Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y, 1984) |
| "Thirty-six patients with hepatocellular carcinoma were treated by hepatic arterial chemoembolization of microencapslated mitomycin C (MMCmc)." | 3.67 | [Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)]. ( Fujii, M; Kamata, R; Sakabe, T; Takano, S; Tanaka, T; Yamaguchi, T, 1988) |
| "Intraarterial infusion therapy combining dibutyryl adenosine 3',5'-monophosphate and mitomycin C was administered to 8 patients with hepatocellular carcinoma occluding the main portal vein." | 3.67 | Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies. ( Ishii, K; Karube, H; Okabe, H; Okudaira, M; Shibata, H; Tsuchiya, M, 1989) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 3.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| "Of 66 patients with hepatocellular carcinoma, 32 were treated by intraarterial injection of mitomycin C microcapsules (group A) and 34 patients by intraarterial injection of mitomycin C microcapsules followed by transcatheter hepatic artery embolization (group B)." | 3.67 | Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma. ( Iida, S; Nomura, F; Ohnishi, K; Sugita, S; Tanabe, Y, 1987) |
| "An intra-arterial injection of an Adriamycin-Lipiodol emulsion and a Mitomycin C microcapsule has been given to two patients of hepatocellular carcinoma (HCC) complicated with a tumor thrombosis of the portal trunk." | 3.67 | [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis]. ( Abe, T; Iizuka, H; Katakai, S; Nagamine, T; Ojima, T; Saitoh, S; Takagi, H; Takayama, H; Takezawa, J; Uehara, M, 1988) |
| " Lp-TAE through the hepatic artery was performed on ten primary hepatocellular carcinoma patients using Gelfoam in combination with adriamycin (40 mg) or mitomycin C (20 mg), emulsified in Lipiodol (10 ml) and 60% Urografin (2 ml)." | 3.67 | [Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization]. ( Ashihara, T; Kagawa, K; Kamachi, M; Sawai, K; Shimamura, Y; Shimotsuma, M; Takahashi, T; Taniguchi, H, 1988) |
| "In 23 patients with hepatocellular carcinoma, accumulating patterns of Lipiodol on CT and therapeutic effects in combination therapy with adriamycin/mitomycin C-oil suspension (ADMOS) and Cis-diamminedichloroplatinum II (CDDP)two-route infusion were evaluated." | 3.67 | [Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma]. ( Hiraki, Y; Ikeda, K; Itoh, Y; Kobayashi, H; Shinohara, S; Sonoda, T; Yano, T, 1988) |
| "DNA adducts of mitomycin C (MMC) were detected by 32P-postlabeling analysis in both surgical specimens and an autopsy sample of the liver of patients with hepatocellular carcinoma who had received chemotherapy with MMC." | 3.67 | Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis. ( Kato, S; Kim, T; Onda, M; Sato, S; Tajiri, T; Yamashita, K, 1988) |
| "An analysis is done of 40 evaluable patients treated with a combination of 5-Fluorouracil, adriamycin and mitomycin-C for primary hepatocellular carcinoma in Saudi Arabia." | 3.67 | Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C. ( Abdel Satir, A; Al-Idrissi, HY; Al-Kasem, S; Al-Qurain, A; Ibrahim, EM; Satti, MB, 1985) |
| "Four patients with advanced hepatocellular carcinoma, but with stage I functional disease, were treated with intrahepatic arterial lipoidal mixed with small doses of Adriamycin (20 mg) and Mitomycin C (10 mg)." | 3.67 | Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C. ( Chin, JH; Oon, CJ; Tan, L; Yong, YM, 1986) |
| "Survival period of 28 cases with unresectable hepatocellular carcinoma treated with transhepatic arterial one-shot infusion of 30 mg mitomycin C (MMC) were retrospectively reviewed from the standpoint of hepatic angiographic findings, scintigraphic existence of liver cirrhosis and changes of AFP value." | 3.66 | [Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C]. ( Kobayashi, H, 1982) |
| "Twenty elderly patients with hepatocellular carcinoma were treated with 5-fluorouracil (5-FU) at a daily dose of 200-300 mg per os, and with a combination of 0." | 3.66 | [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil]. ( Asano, K; Ejiri, T; Fujii, M; Matsuka, Y; Murakami, N, 1982) |
| "Twenty patients with hepatocellular carcinoma treated with chemoembolization were included in the study." | 2.78 | Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography. ( Beilner, J; Chen, JJ; Chi, JC; Kowarschik, M; Xu, JR; Ye, H; Zhang, XB; Zhuang, ZG, 2013) |
| "A total of 29 patients (n=13 for chronic hepatitis Band n=16 for chronic hepatitis C) showed significant changes of the viral loads after TACE." | 2.76 | Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma. ( Chen, SH; Chuang, WL; Hsieh, MY; Huang, CF; Lin, CI; Lin, ZY, 2011) |
| "Treatment of hepatocellular carcinoma (HCC) with transcatheter arterial chemoembolization (TACE) is known to induce vascular endothelial growth factor (VEGF) expression." | 2.73 | The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE). ( Ket-Horm, S; Kiatdilokrut, A; Laisupasin, P; Leelawat, K; Narong, S; Pongtongpool, T; Samkhumphim, N, 2008) |
| "To evaluate the effect of tamoxifen (TAM) combined with a somatostatin analogue, octretide (OCT) on advanced liver cancer and whether tamoxifen combined with OCT is superior to regular chemotherapeutic agents 5-Fu and mitomycin C (MMC)." | 2.71 | Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial. ( Chen, JW; Huo, YC; Pan, DY; Qiao, JG; Shi, HA; Zhou, YK, 2003) |
| "To investigate the effects of the dosage of anticancer agents during transcatheter arterial chemoembolization (TACE) on the T cell subsets in patients with hepatocellular carcinoma (HCC)." | 2.70 | Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma. ( Chen, Y; He, XF; Li, YH; Lu, W; Qiu, YR; Zeng, QL, 2002) |
| "Recurrence of hepatocellular carcinoma (HCC) after curative hepatic resection is frequent and is an important factor adversely influencing long-term survival." | 2.69 | Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. ( Chang, FY; Chau, GY; Chiang, JH; Huang, YH; Huo, TI; King, KL; Lee, SD; Lui, WY; Tsay, SH; Wu, JC, 2000) |
| "In the 110 patients with metastatic liver cancer, the carcinoembryonic antigen level and tumor size were reduced." | 2.67 | Targeted chemotherapy for unresectable primary and metastatic liver cancer. ( Kai, Y; Kimura, M; Konno, T; Nagamitsu, A; Yamashita, R, 1994) |
| "Mitomycin was used in 40 patients and dihydroxyanthracenedione (DADH) in 58 patients." | 2.67 | [The treatment of hepatocellular carcinoma by chemoembolization]. ( Bortolasi, L; Dal Dosso, I; Facci, E; Mansueto, GC; Marchiori, L; Nicoli, N; Nifosi, F; Perus, G, 1994) |
| "Vascular invasion and intrahepatic metastasis by hepatocellular carcinoma are important factors predisposing to tumor recurrence." | 2.67 | Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. ( Ii, T; Iyobe, T; Izumi, R; Matsui, O; Miyazaki, I; Nonomura, A; Shimizu, K; Yagi, M, 1994) |
| "Fifty-two patients with unresectable hepatocellular carcinoma were divided into 2 groups." | 2.67 | Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma. ( Lu, CD; Peng, SY; Qi, YG, 1994) |
| "Twenty-six cases of hepatocellular carcinoma were divided randomly into 3 groups, treated by transcatheter hepatic arterial chemo-embolizations with agents of MMC 20 mg, MMC 20 mg plus lipiodol 10 ml, and MMC 20 mg plus MTXmc 150 mg, respectively, 2 to 3 weeks before surgery." | 2.67 | [Histologic assessment on resected hepatocellular carcinoma specimens with preoperative transcatheter hepatic arterial chemo-embolizations]. ( Chen, H, 1991) |
| "As the prevalence of liver cancer increases, so does the demand for nonsurgical, minimally invasive alternatives to surgery, since many patients have tumors that cannot be surgically resected." | 2.52 | Catheter-based transarterial therapies for hepatocellular cancer. ( Laroia, AT; Laroia, ST; Morales, SA, 2015) |
| "20 patients had Barcelona Clinic Liver Cancer (BCLC) stage B, while 8 patients obtained chemoembolization for bridging purposes (BCLC stage A)." | 1.48 | Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients. ( Beeres, M; Eichler, K; Gruber-Rouh, T; Kamal, A; Langenbach, M; Naguib, NN; Vogl, TJ, 2018) |
| "The treatment efficacy of unresectable hepatocellular carcinoma (HCC) is still not promising." | 1.43 | Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study. ( Bao, Y; Dai, Y; Dong, X; Feng, W; Shen, J; Tang, C; Zhang, J; Zheng, Y, 2016) |
| "On day 0 a solid Morris Hepatoma 3924A was subcapsullary implanted in the liver." | 1.43 | Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol. ( Bechstein, WO; Gruber-Rouh, T; Hamidavi, Y; Hammerstingl, R; Imlau, U; Korkusuz, H; Naguib, NN; Nour-Eldin, NE; Oppermann, E; Qian, J; Tran, A; Vogl, TJ, 2016) |
| "The clinicopathological parameters and adverse effects were similar between the 2 groups (P > 0." | 1.42 | Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection. ( Burns, M; Hong, Y; Lei, X; Li, JL; Li, QL; Li, YG; Liu, C; Liu, HC; Liu, JS; Qiu, XX; Wang, XH; Wu, QF; Xia, M; Xiao, H; Xu, RC; Zhu, HZ; Zuo, CH, 2015) |
| "Furthermore, MMC alone enhanced genomic instability, but MMC combined with AET attenuated the extent of genomic instability in primary VX2 tumor tissue." | 1.42 | Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells. ( Bei, J; Feng, F; Feng, Q; Hong, J; Hu, W; Kang, T; Liang, Y; Peng, R; Sang, Y; Xu, M; Zeng, Y, 2015) |
| "A major challenge of combinatorial therapy is the unification of the pharmacokinetics and cellular uptake of various drug molecules with precise control of the dosage thereby maximizing the combined effects." | 1.42 | Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy. ( Cao, Y; Gu, Y; Guo, P; He, H; Huang, X; Lei, S; Liu, M; Luo, S; Mukerabigwi, JF; Zhang, Y, 2015) |
| "Many advanced hepatocellular carcinoma (HCC) cases can be successfully downstaged into the Milan criteria; however, immediate radical therapy cannot be applied to all such patients for various reasons." | 1.40 | Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE. ( Jiang, L; Lei, JY; Li, B; Wang, WT; Wei, YG; Wen, TF; Xu, MQ; Yan, LN; Yang, JY, 2014) |
| "The prognosis of hepatocellular carcinoma (HCC) with macroscopic vascular invasion is extremely poor even after hepatic resection." | 1.39 | Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion. ( Baba, H; Beppu, T; Chikamoto, A; Hayashi, H; Imai, K; Nitta, H, 2013) |
| "To evaluate the anti-tumor effect of intra-arterial IL-12 gene delivery alone and in combination with transcatheter arterial chemoembolization (TACE) in rabbit VX2 liver cancer model." | 1.39 | Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model. ( Feng, G; Li, X; Liang, H; Xia, X; Zheng, C; Zhou, G, 2013) |
| "A total of 40 patients with hepatocellular carcinoma treated with transarterial chemoembolization between January 2007 and March 2011 were included." | 1.39 | Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience. ( Altundağ, K; Balkancı, F; Bayraktar, Y; Cil, BE; Doğanay Erdoğan, B; Idilman, I; Kav, T; Peynircioğlu, B; Yalçın, S, 2013) |
| " In conclusion, even after particle therapy, PIHP is a safe treatment and is associated with a good local control rate for remnant HCCs." | 1.39 | [Analysis of the safety and efficacy of percutaneous isolated hepatic perfusion after particle therapy for advanced hepatocellular carcinoma]. ( Ajiki, T; Demizu, Y; Fujii, O; Fukumoto, T; Fukushima, K; Fuwa, N; Kido, M; Kinoshita, H; Komatsu, S; Ku, Y; Kuramitsu, K; Matsumoto, I; Shinzeki, M; So, S; Takebe, A; Tanaka, M; Terashima, K; Urade, T, 2013) |
| "Twenty-four hepatocellular carcinomas were targeted in 18 patients (14 men, four women; mean age, 66 years), and segmental or lobar chemoembolization with intraprocedural transcatheter intraarterial perfusion MRI was successful in all 18." | 1.38 | Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI. ( Gaba, RC; Jin, B; Larson, AC; Lewandowski, RJ; Omary, RA; Ragin, AB; Salem, R; Wang, D, 2012) |
| "Thirty-six hepatocellular carcinoma patients not indicated for surgical resection underwent super- selective transcatheter arterial chemoembolization, divided into small dose (n=15) and conventional dose (n=21) chemotherapy groups." | 1.38 | Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. ( Hu, Y; Li, H; Li, N; Zhou, Y, 2012) |
| "To (a) evaluate the response of hepatocellular carcinoma (HCC) to chemoembolization after initial nonresponse, as determined with European Association for the Study of the Liver (EASL) criteria and modified Response Evaluation Criteria in Solid Tumors (mRECIST), and (b) compare posttreatment survival of initial nonresponders versus that of initial responders." | 1.38 | Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? ( Frangakis, C; Georgiades, C; Geschwind, JF; Harrison, N; Hines-Peralta, A; Hong, K; Kamel, I; Liapi, E; Wu, Z, 2012) |
| "The recurrence of hepatocellular carcinoma is still high even after surgery." | 1.37 | Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. ( Hayami, S; Ozawa, S; Shigekawa, Y; Tani, M; Uchiyama, K; Ueno, M; Yamaue, H, 2011) |
| "Among 11,030 patients with unresectable hepatocellular carcinoma, 8,507 underwent TACE, and 2,523 underwent transarterial infusion therapy with an emulsion of iodized oil and an anticancer agent as initial treatment." | 1.36 | Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. ( Arii, S; Ikai, I; Kojiro, M; Kudo, M; Makuuchi, M; Matsuyama, Y; Takayasu, K, 2010) |
| "Established human hepatocellular carcinoma adriamycin (ADM) multi-drug resistant cell sub-lines models Bel-7402/ADMV, Bel-7402/ADML and Bel-7402/ADMS by three methods of in vitro concentration gradient increased induction, nude mice liver-implanted induction and subcutaneous-implanted induction respectively." | 1.36 | Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods. ( Gong, R; Meng, X; Xiong, M; Zhong, X, 2010) |
| "We herein report a case of advanced hepatocellular carcinoma (HCC) with Vp4 portal vein thrombosis (PVTT)." | 1.36 | [A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion]. ( Awazu, M; Chuma, M; Fukumoto, T; Hori, Y; Kataoka, Y; Kido, M; Ku, Y; Kuroda, D; Kusunoki, N; Matsumoto, I; Takahashi, M; Tsuchida, S; Tsugawa, D, 2010) |
| "A case of hepatocellular carcinoma, successfully treated with multimodal loco-regional treatments, is reported." | 1.36 | [Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report]. ( Akiyama, H; Amikura, K; Kawashima, Y; Nakajima, T; Nishimura, Y; Sakamoto, H; Tanaka, Y; Yamagata, Y; Yamaura, T; Yatsuoka, T; Yokoyama, Y, 2010) |
| "There were upper gastrointestinal hemorrhage in 3 cases, hepatic failure in 4, pulmonary embolism in 1, cholecystitis in 4, hepatic encephalopathy in 2, gastric perforation in 1, and intrahepatic biloma in 2 cases." | 1.35 | [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma]. ( Feng, B; Liang, SN; Liu, LL; Su, HY; Xu, K; Zhao, GS, 2008) |
| "To evaluate the outcomes of patients with unresectable massive primary liver cancer (PLC) receiving three-dimensional conformal radiotherapy (3-DCRT) combined with transcatheter arterial chemoembolization (TACE)." | 1.35 | [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer]. ( Chen, LH; Guan, J; Li, QS; Sun, HW; Wei, CJ; Zheng, XK, 2009) |
| " The TACE-procedure was carried out in regular intervals using a suspension consisting of a fixed dosage of Mitomycin C (10 mg) and 10-20 ml Lipiodol." | 1.34 | [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences]. ( Düber, C; Herber, S; Junginger, T; Kanzler, S; Kummer, I; Manzl, N; Mönch, C; Otto, G; Pitton, M; Schneider, J; Schuchmann, M, 2007) |
| "Huh7 hepatoma cells were transfected with a caspase-8 promoter construct fused to a luciferase reporter gene followed by stimulation with a subset of different chemotherapeutic drugs." | 1.34 | Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-alpha signalling. ( Lambertz, D; Liedtke, C; Schnepel, N; Trautwein, C, 2007) |
| "Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered to be poor." | 1.33 | [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C]. ( Ahn, SH; Cho, KB; Choi, JS; Chung, WJ; Hwang, JS; Hwang, JY; Jang, BK; Kim, GC; Kim, YH; Kwon, JH; Kwon, KM; Park, KS, 2005) |
| " Low-output RFA combined with TACE is a safe, effective therapy for HCC." | 1.33 | [Low-output radiofrequency ablation combined with transcatheter arterial oily-chemoembolization for hepatocellular carcinoma]. ( Higashi, K; Kimura, M; Maeda, M; Nakai, M; Sahara, S; Sato, M; Shiraki, T; Takeuchi, N; Terada, M, 2005) |
| "To introduce an animal model of hepatocellular carcinoma (HCC) in ACI-rats, and to evaluate the therapeutic effects of Poly-lactide-co-glycolide (Plcg) -microspheres in the transarterial chemoembolization (TACE) in this model, as well the value of this model in the experiments of interventional therapy." | 1.32 | Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. ( Claussen, C; Eul, T; Graepler, F; Huppert, P; Pereira, P; Qian, J; Truebenbach, J; Wiemann, G, 2003) |
| "A patient with liver metastasis of pancreatic cancer received chemotherapy using mitomycin C and degradable starch microspheres." | 1.32 | Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheres. ( Aoki, T; Kato, F; Katsumata, K; Koyanagi, Y; Sumi, T; Suzuki, Y; Takagi, M; Tomioka, H; Yamasaki, T, 2003) |
| "Hepatic resection for huge hepatocellular carcinoma (HCC) is challenging." | 1.32 | Multimodality management of hepatocellular carcinoma larger than 10 cm. ( Chen, IS; Chen, YC; Chou, NH; Liang, HL; Liu, SI; Lo, GH; Mok, KT; Tsai, CC; Wang, BW; Yeh, MH, 2003) |
| "5-fluorouracil (5-FU) that has no carbonyl group was used as control." | 1.32 | [Screening of the drug resistance-associated gene in HepG2 cell line transfected with aldose reductase like gene-1 (ARL-1)]. ( Cao, DL; Tang, DN; Wang, J; Yang, XD, 2003) |
| "Large hepatocellular carcinoma tumors are being treated increasingly with a combination of transcatheter arterial chemoembolization (TACE) and radiofrequency (RF) ablation." | 1.32 | 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. ( Ahrar, K; Newman, RA; Pang, J; Vijjeswarapu, MK; Wallace, MJ; Wright, KC, 2004) |
| "To explore the change of T cell subsets in patients suffered from hepatocellular carcinoma (HCC) before and after hepatectomy, and study the value of Roferon-A (interferon alpha-2a) combined with hepatic artery chemoembolization (HACE) and portal vein chemotherapy (PVC) after radical resection of HCC for preventing recurrence." | 1.32 | [The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy after radical resection in hepatocellular carcinoma for preventing recurrence]. ( Chen, JS; Duan, ZH; Li, HH; Wang, J; Zhang, HW, 2004) |
| "A 73-year old man with multiple hepatocellular carcinomas underwent 4 transarterial chemoembolizations, but a tumor thrombus appeared in the left portal vein." | 1.31 | [A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization]. ( Esumi, K; Furukawa, H; Imamura, H; Inoue, Y; Ishida, H; Katoh, H; Kitani, K; Masuda, N; Masutani, S; Onishi, H; Shimizu, J; Tatsuta, M; Tomotsu, K; Tsuda, K; Usui, T, 2002) |
| "Synergistic inhibition of hepatoma BEL-7402 cell proliferation was achieved by the combination of MMC and CA-Na." | 1.31 | [Synergistic antitumor effect of sodium caffeate and mitomycin]. ( Song, DQ; Xu, F; Zhen, YS, 2002) |
| "Transplantable murine hepatoma 22 model was used to evaluate the antitumor activity of drugs in vivo." | 1.31 | Synergistic effects of geldanamycin and antitumor drugs. ( Liao, ZY; Zhang, SH; Zhen, YS, 2001) |
| "For most patients with primary liver cancer surgical treatment is not feasible and prognosis without treatment is poor." | 1.31 | Chemoembolization for primary liver cancer. ( Achenbach, T; Junginger, T; Pitton, MB; Schunk, K; Seifert, JK, 2002) |
| "Reports about arteritis during TACE treatments are discussed." | 1.30 | Arteritis following intra-arterial chemotherapy for liver tumors. ( Belli, L; Colombo, E; Cornalba, GP; Damiani, G; Magistretti, G; Puricelli, GP, 1997) |
| "Mitomycin C pretreatment also significantly increased the sensitivity of cancer cells to subsequent killing by the P-glycoprotein substrate doxorubicin, decreasing the ED50 by 5- to 10-fold." | 1.30 | Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. ( Blaxall, JR; Hamilton, JW; Ihnat, MA; La Ronde, N; Lariviere, JP; Pierre, KM; Turpie, BW; Warren, AJ, 1997) |
| "Although gamma-irradiated human HepG2 hepatoma cells have been used recently for chemical activation, an alternative is now needed due to scheduled retirement of the available gamma-source." | 1.30 | Comparison of HepG2 feeder cells generated by exposure to gamma-rays, X-rays, UV-C light or mitomycin C for ability to activate 7,12-dimethylbenz[a]anthracene in a cell-mediated Chinese hamster V79/HGPRT mutation assay. ( Schrader, TJ, 1999) |
| "Advanced hepatocellular carcinoma (HCC) with extensive tumour growth through the hepatic vein still has an extremely poor prognosis, even after cancer chemotherapy and/or transarterial embolization." | 1.30 | Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. ( Ambiru, S; Furuya, S; Ito, H; Kaiho, T; Kashima, Y; Miyazaki, M; Nakagawa, K; Nakajima, N; Shimizu, H, 1999) |
| "Lovastatin-treated cells also exhibited decreased adherence to substrate (p < 0." | 1.29 | Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth. ( Buchwald, H; Furcht, LL; Morris, TJ; Palm, SL, 1995) |
| "Mitomycin C was also used in four cases." | 1.29 | Multiple intrahepatic aneurysms following transcatheter arterial embolization. Work in progress. ( Aikawa, H; Ashizawa, K; Aso, N; Fukuda, T; Fukushima, T; Hayashi, K; Isomoto, I; Matsunaga, N; Morikawa, M; Sakamoto, I, 1994) |
| "AH109A rat ascites hepatoma cells (2 x 10(6)) were subcutaneously implanted in the back of male Donryu rats (n = 32, body weight 150-200 g) on Day 0." | 1.29 | Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats. ( Ishibashi, N; Kaibara, A; Kakegawa, T; Yamasaki, K; Yoshida, S, 1994) |
| "We describe a case of hepatoma, a 66-year-old woman, presenting with obstructive jaundice, whom we treated with intra-arterial infusion of the anticancer drug, MMC." | 1.29 | [A case of icteric type hepatoma responding to MMC infusion therapy via cannulation into the hepatic artery]. ( Kato, S; Kobayashi, H; Nakagawa, T, 1993) |
| "125 cases of hepatocellular carcinoma (HCC) were treated by transarterial approach." | 1.29 | [Treatment of hepatocellular carcinoma by transarterial approach]. ( Luo, PF, 1993) |
| "A 64-year-old male was admitted for treatment of hepatocellular carcinoma." | 1.28 | [A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C]. ( Eto, T; Ishinoda, Y; Iwaki, Y; Kawano, T; Kitamura, M; Kitamura, T; Komura, K; Maruyama, T; Shimada, Y; Tamaki, N, 1992) |
| "Mitomycin C was observed potentially to have enhanced cytotoxicity under hypoxic conditions for both hepatoma cell lines." | 1.28 | The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions. ( Ikeda, Y; Kanematsu, T; Matsumata, T; Sugimachi, K; Utsunomiya, T; Yamagata, M, 1992) |
| "Hepatectomy has been performed as a treatment for hepatocellular carcinoma (HCC) and metastatic liver carcinoma." | 1.28 | [Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma]. ( Hanawa, S; Hasebe, Y; Kuramoto, S; Maeda, T; Nakazaki, H; Suzuki, Y; Watanabe, M; Yanagita, K; Yoshio, T, 1992) |
| "Nine patients with inoperable hepatoma were treated by using hepatic arterial embolization 131I and chemotherapeutic agent gelatin microsphere (131I-CA-GM)." | 1.28 | [Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases]. ( Chen, X; Li, L; Li, X; Tan, T; Wu, Y; Xie, X; Yan, C; Zhong, D, 1992) |
| "21 cases of hepatocellular carcinoma (HCC) were surgically resected about 14 or 21 days after transcatheter hepatic arterial chemo-embolization (TACE) mostly for histopathologic assessment of effectiveness." | 1.28 | [Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization]. ( Dai, Y, 1991) |
| "Chemosensitivity of hepatocellular carcinoma tissues from 72 patients to 6 antitumor agents was assayed using the succinate dehydrogenase inhibition test." | 1.28 | Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test. ( Akazawa, K; Kanematsu, T; Maehara, Y; Matsumata, T; Shirabe, K; Sugimachi, K, 1991) |
| "From 1986 to 1988, 35 patients with a hepatoma judged either inoperable or unresectable because of coexistent cirrhosis were treated with hepatic arterial embolization of mitomycin C microcapsules." | 1.28 | Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. ( Audisio, RA; Bellegotti, L; Damascelli, B; DeFazio, C; Doci, R; Marchianò, A; Mazzaferro, V; Montalto, F; Piva, A; Tommasini, M, 1990) |
| "In 36 patients with hepatocellular carcinoma treated with transcatheter arterial infusion and embolization, the arithmetic mean survival time after treatment was 412." | 1.28 | [Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma]. ( Akai, S; Kato, K; Kato, T; Nashimoto, A; Niwa, M; Ogoshi, K; Saito, Y; Shimizu, K, 1990) |
| "Some 222 of H." | 1.28 | [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer]. ( Akaza, K; Harada, A; Isshiki, K; Katoh, H; Kishimoto, W; Nakao, A; Nonami, T; Takagi, H, 1990) |
| " Thus, both intraarterial and intraportal chemotherapy combined with decollateralization by silicone rubber sheeting seems to be effective for advanced cholangiocarcinoma and metastatic carcinoma." | 1.28 | [Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer]. ( Fukuda, I; Furukawa, H; Imaoka, S; Ishikawa, O; Masutani, S; Nagano, H; Ohashi, I; Oohigashi, H; Sasaki, Y; Yasuda, T, 1990) |
| "Reported is the case of a hepatocellular carcinoma with a complete remission of the bone metastasis by arterial chemotherapy." | 1.28 | [Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy]. ( Aoki, Y; Fujimoto, T; Fukushima, H; Hirai, K; Iwai, I; Majima, Y; Nakashima, O; Shimada, M; Tanaka, M; Yamashita, K, 1990) |
| "A new immunotherapy for hepatocellular carcinoma (HCC) using Freund's adjuvant and recombinant interleukin-2 (IL-2) combined with conventional transarterial chemoembolization therapy was performed." | 1.28 | Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma. ( Higashi, T; Ikeda, N; Ito, T; Nouso, K; Ohsawa, T; Okamoto, T; Sue, K; Tsuji, T; Ukida, M; Watanabe, A, 1989) |
| "Six cases of unresectable hepatic cancer in infant were treated with intra-arterial infusion therapy." | 1.28 | [Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children]. ( Abe, T; Hamada, H; Hata, Y; Saito, H; Sasaki, F; Sato, N; Sawada, H; Tamura, M; Uchino, J; Une, Y, 1989) |
| "Hepatocellular carcinoma is the most common cause of cancer death in Thai males." | 1.28 | High-dose mitomycin C: activity in hepatocellular carcinoma. ( Auethaveekiat, V; Cheirsilpa, A; Kangsumrit, N; Leelasethakul, S; Maoleekulpriroj, S; Phanthumjida, P; Thanakaravit, P, 1989) |
| "In the case of gall bladder cancer cell line (NOZ), combination of adriamycin and hyperthermia showed more effective inhibition for cell proliferation than MMC + hyperthermia and 5-FU + hyperthermia." | 1.28 | [Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro]. ( Fujise, K; Hasumura, S; Homma, S; Kameda, H; Matsuura, T; Nagamori, S; Niiya, M; Shimizu, K; Sujino, H, 1989) |
| "Three cases of ruptured hepatocellular carcinomas were treated: one case by emergency hepatectomy, and two cases by hepatectomy following TAE." | 1.28 | [Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma]. ( Itoh, H; Kaiho, T; Kanno, Y; Kimura, F; Koshikawa, H; Matsumoto, J; Miyazaki, M; Nakajima, T; Teramoto, O; Udagawa, I, 1989) |
| "Lipiodol-ADM was injected for hepatocellular carcinoma every 2 months and MMC-5-FU was injected for liver metastasis of colorectal carcinoma every one or two weeks." | 1.28 | [Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma]. ( Adachi, W; Hanasaki, K; Horigome, N; Iida, F; Kajikawa, S; Kinosita, T; Kuroda, T; Sodeyama, H, 1989) |
| "In 24 cases of unresectable hepatocellular carcinoma, we performed hepatic arterial catheterization and intra-arterial infusion chemotherapy." | 1.28 | [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma]. ( Amioka, K; Hara, H; Iga, C; Ishibashi, T; Isozaki, H; Morita, S; Nakata, E; Nishimura, J; Okajima, K; Tanimura, M, 1989) |
| "Of the 8 patients having hepatoma with increased AFP, all the patients showed a decrease of AFP following the therapy with an average ratio of 65% decrease." | 1.28 | [Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]. ( Haida, K; Miura, T, 1989) |
| "Hepatocellular carcinoma was diagnosed by various imaging techniques and the patient was treated by 3 transarterial embolizations and 2 courses of systemic chemotherapy with CDDP." | 1.28 | [A resected case of hepatocellular carcinoma effectively treated by hepatic artery embolization and systemic chemotherapy]. ( Araki, I; Kobayashi, T; Noda, M; Sekikawa, H; Shinagawa, T; Yoshida, M, 1989) |
| "Twelve of the patients had primary hepatocellular carcinoma and six had metastatic liver carcinoma originating from an unknown primary site." | 1.27 | Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver. ( Benjamin, RS; Chuang, VP; Fuqua, R; Mavligit, GM; Patt, YZ; Wallace, S, 1983) |
| "Eleven unresectable hepatoma patients and three metastatic tumor patients with colonic cancer underwent ligation and/or catheterization of the hepatic artery of the main tumor-bearing zone." | 1.27 | Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors. ( Ashizawa, T; Kido, C; Morimoto, T; Ochiai, E; Takagi, H; Yamada, E; Yasue, M, 1983) |
| "Sixty-seven patients with advanced hepatoma were treated with intra-arterial MMC-mc during the period from 1978 to 1982." | 1.27 | [Chemo-embolization with mitomycin C microcapsules for hepatoma]. ( Kato, T; Tamakawa, Y; Unno, K, 1984) |
| "Of 20 patients with inoperable hepatocellular carcinoma (HCC) treated with one or more courses via a hepatic arterial catheter, a change in tumor size could be measured in 16." | 1.27 | Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. ( Goto, N; Hiyama, Y; Iwama, S; Kono, K; Nakajima, Y; Nakayama, T; Ohnishi, K; Ohtsuki, T; Takashi, M; Tsuchiya, S, 1984) |
| "Especially in liver metastasis of the breast cancer, MMC-m." | 1.27 | [Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer]. ( Itoh, J; Katoh, T; Nakagawa, H; Sasaki, H; Takahashi, T, 1983) |
| "Fourty eight patients with cancer of head of pancreas have been treated by the intra-arterial infusion of 5-FU and Mitomycin C alone or in combination with regional hyperthermia, employing microwave machine operating at a frequency of 2450 MHz." | 1.27 | [Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas]. ( Endo, Y; Funatomi, H; Hatta, Y; Hirose, N; Miura, T; Sassa, T; Taguchi, S; Yoshikawa, N, 1985) |
| "Thirty-two patients with inoperable hepatic cancer underwent intra-arterial hepatic infusion using mitomycin C (MMC) and 5-fluorouracil (5-FU) or intra-arterial hepatic chemoembolization using heated albumin microspheres containing MMC with an average diameter 45 +/- 8 micron." | 1.27 | Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. ( Endoh, F; Fujimoto, S; Miyazaki, M; Morimoto, Y; Okui, K; Takahashi, O, 1985) |
| "One patient with hepatocellular carcinoma shunted only 24% of the macroaggregated albumin, and flow through the liver was reduced to 48% by DSM therapy." | 1.27 | Initial clinical experience with degradable starch microspheres. ( Giles, GR; Mavor, AI; O'Brien, T; Parkin, A; Riley, A; Robinson, PJ; Smye, S, 1987) |
| "Of the 8 patients with hepatoma with increased AFP, all the patients showed a decrease of AFP following therapy with an average decrease ratio of 64%." | 1.27 | [Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies]. ( Haida, K; Miura, T, 1988) |
| "Adriamycin + DSM was administered for hepatocellular carcinoma, and Mitomycin C + DSM was used for metastatic liver cancer." | 1.27 | [Multidisciplinary treatment of unresectable liver cancer]. ( Hattori, T; Kodama, H; Kuninobu, H; Niimoto, M; Nishiyama, M; Saeki, T; Toge, T; Yoshinaka, K, 1988) |
| "In the patients with metastatic liver cancer, tumor regression over 50% was observed in 65% of the patients treated with chemoembolization alone and in 33% of those with chemoembolization and HT." | 1.27 | [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors]. ( Itani, K; Kondo, M; Oyamada, H; Seto, O; Sugino, S; Tainaka, K; Yoshikawa, T, 1988) |
| " No significant side effect was noted in any case." | 1.27 | [Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect]. ( Ikami, I; Kanehira, J; Midorikawa, H; Saito, Y; Sasaki, T; Takekawa, SD; Tarusawa, K; Yodono, H, 1988) |
| "A multidisciplinary treatment for hepatocellular carcinoma including preoperative chemo-embolization with resection treatment was introduced." | 1.27 | [Preoperative chemo-embolization for treatment of hepatocellular carcinoma]. ( Kuroda, C; Monden, M; Mori, T; Okamura, J; Sakon, M; Sakurai, M; Wakasa, K; Yoshioka, H, 1985) |
| "Twenty-two patients with hepatocellular carcinoma were treated with transcatheter arterial embolization therapy." | 1.27 | [Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy]. ( Fujii, H; Iwai, M; Miyoshi, M; Suyama, Y, 1985) |
| "A total of 850 patients with hepatocellular carcinoma seen during the last 8 years were analyzed retrospectively for survival in relation to treatment and disease stage." | 1.27 | Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. ( Hasegawa, H; Nakajima, Y; Obata, H; Ohnishi, K; Ohtsuki, T; Okazaki, N; Okuda, K; Tomimatsu, M, 1985) |
| "407 cases of unresectable hepatocellular carcinoma (HCC) occurring from 1970 to March 1985, including 107 cases receiving conservative therapy, 176 cases receiving one-shot therapy and 124 cases receiving transcatheter arterial embolization (TAE) therapy, were studied and the efficacy of chemotherapy was compared with that of TAE therapy." | 1.27 | [One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma]. ( Abe, M; Hirai, K; Kawazoe, Y; Kumagai, M; Tanikawa, K; Yamashita, K, 1985) |
| "The patient also had autoimmune hemolytic anemia." | 1.27 | [Chemotherapy of balloon-occluded arterial infusion in a patient with unresectable hepatocellular carcinoma and autoimmune hemolytic anemia]. ( Fujio, N; Hirohashi, K; Iwasa, R; Kinoshita, H; Kubo, S; Nakatsuka, H; Sakai, K; Takashima, S, 1986) |
| "In metastatic liver cancer, tumor regression of over 50% was observed in 4 of 8 cases." | 1.27 | [Chemoembolization with degradable starch microspheres in malignant hepatic tumors]. ( Hotta, T; Itani, K; Kondo, M; Naito, Y; Seto, O; Sugino, S; Tainaka, K; Yoshikawa, T, 1987) |
| " the same therapy in combination with UFT as a maintenance therapy (group B; 8 patients)." | 1.27 | [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma]. ( Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M, 1987) |
| "The MMC MS treatment for metastatic hepatic cancer had superiority to the conventional infusion treatment at p = 0." | 1.27 | [Intra-arterial chemoembolization with albumin microspheres including mitomycin C in inoperable hepatic cancer]. ( Endoh, F, 1987) |
| "Forty patients with hepatoma and metastatic tumors of liver were treated with rapid arterial infusion administered simultaneously using 30-40 mg of adriamycin and 10-20 mg of mitomycin C into the hepatic artery by Seldinger catheter." | 1.26 | [Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver]. ( Aiba, K; Domyo, M; Ezaki, K; Horikoshi, N; Inagaki, J; Inoue, K; Miyamoto, H; Nagata, T; Ogawa, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 107 (28.69) | 18.7374 |
| 1990's | 114 (30.56) | 18.2507 |
| 2000's | 82 (21.98) | 29.6817 |
| 2010's | 66 (17.69) | 24.3611 |
| 2020's | 4 (1.07) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, YC | 1 |
| Prakash, CV | 1 |
| Chen, YJ | 1 |
| Hwang, JF | 1 |
| Kuo, YH | 1 |
| Chen, CY | 2 |
| Yu, X | 1 |
| Zhang, Q | 1 |
| Tian, L | 1 |
| Guo, Z | 1 |
| Liu, C | 2 |
| Chen, J | 1 |
| Ebrahim, W | 1 |
| Liu, Z | 1 |
| Proksch, P | 1 |
| Zou, K | 1 |
| Hund, HC | 2 |
| Frantz, SK | 2 |
| Wu, H | 2 |
| Adeniran, OR | 2 |
| Wong, TY | 2 |
| Borgmann, AJ | 2 |
| Matsuoka, L | 2 |
| Geevarghese, S | 3 |
| Alexopoulos, S | 2 |
| Shingina, A | 2 |
| Meranze, SG | 2 |
| Baker, JC | 3 |
| Garbett, S | 2 |
| Brown, DB | 6 |
| Hori, A | 4 |
| Ohira, R | 1 |
| Nakamura, T | 2 |
| Kimura, Y | 1 |
| Ueda, S | 1 |
| Torii, M | 1 |
| Kennoki, N | 1 |
| Hori, S | 2 |
| Mei, N | 1 |
| Zhao, N | 1 |
| Tian, T | 1 |
| Jiao, M | 1 |
| Li, C | 3 |
| Gruber-Rouh, T | 4 |
| Schmitt, C | 1 |
| Naguib, NNN | 1 |
| Nour-Eldin, NA | 1 |
| Eichler, K | 5 |
| Beeres, M | 2 |
| Vogl, TJ | 7 |
| Fritsche, MR | 1 |
| Watchmaker, JM | 1 |
| Lipnik, AJ | 1 |
| Banovac, F | 1 |
| Omary, RA | 4 |
| Kissane, J | 1 |
| Waybill, P | 1 |
| Kamal, A | 1 |
| Naguib, NN | 3 |
| Langenbach, M | 1 |
| Miyata, T | 1 |
| Beppu, T | 2 |
| Imamura, YU | 1 |
| Hayashi, H | 2 |
| Imai, K | 2 |
| Chikamoto, A | 2 |
| Yamashita, YI | 1 |
| Fukubayashi, K | 1 |
| Ishiko, T | 1 |
| Baba, H | 2 |
| He, M | 1 |
| Li, Q | 4 |
| Shen, J | 2 |
| Tan, G | 1 |
| Lai, J | 1 |
| Wei, W | 1 |
| Zhang, Y | 2 |
| Zou, R | 1 |
| Chen, M | 1 |
| Guo, R | 1 |
| Shi, M | 3 |
| Nitta, H | 1 |
| Yu, SJ | 1 |
| Lee, JH | 2 |
| Jang, ES | 1 |
| Cho, EJ | 1 |
| Kwak, MS | 1 |
| Yoon, JH | 2 |
| Lee, HS | 2 |
| Kim, CY | 1 |
| Kim, YJ | 2 |
| Zhang, XB | 1 |
| Zhuang, ZG | 1 |
| Ye, H | 1 |
| Beilner, J | 1 |
| Kowarschik, M | 1 |
| Chen, JJ | 1 |
| Chi, JC | 1 |
| Xu, JR | 1 |
| Xia, X | 1 |
| Li, X | 4 |
| Feng, G | 1 |
| Zheng, C | 1 |
| Liang, H | 1 |
| Zhou, G | 1 |
| Liu, FY | 2 |
| Wang, MQ | 2 |
| Duan, F | 1 |
| Fan, QS | 1 |
| Song, P | 1 |
| Wang, Y | 3 |
| Idilman, I | 1 |
| Peynircioğlu, B | 1 |
| Cil, BE | 1 |
| Doğanay Erdoğan, B | 1 |
| Yalçın, S | 1 |
| Bayraktar, Y | 1 |
| Kav, T | 1 |
| Altundağ, K | 1 |
| Balkancı, F | 1 |
| Yeh, CT | 2 |
| Liang, KH | 1 |
| Lin, CC | 1 |
| Chang, ML | 2 |
| Hsu, CL | 1 |
| Hung, CF | 1 |
| Fukumoto, T | 4 |
| Tominaga, M | 3 |
| Kido, M | 3 |
| Takebe, A | 2 |
| Tanaka, M | 7 |
| Kuramitsu, K | 2 |
| Matsumoto, I | 3 |
| Ajiki, T | 2 |
| Ku, Y | 5 |
| Nishikawa, H | 3 |
| Osaki, Y | 3 |
| Kita, R | 3 |
| Kimura, T | 3 |
| Ohara, Y | 1 |
| Takeda, H | 2 |
| Sakamoto, A | 2 |
| Saito, S | 2 |
| Nishijima, N | 1 |
| Nasu, A | 2 |
| Komekado, H | 1 |
| Nishiguchi, S | 1 |
| Xiang, J | 1 |
| Xiang, Y | 1 |
| Lin, S | 1 |
| Xin, D | 1 |
| Liu, X | 1 |
| Weng, L | 1 |
| Chen, T | 1 |
| Zhang, M | 1 |
| Zhuo, LJ | 1 |
| Chen, H | 3 |
| Wu, MX | 1 |
| Gao, MQ | 1 |
| Chen, SP | 1 |
| Huang, AM | 1 |
| Kinoshita, H | 2 |
| Komatsu, S | 1 |
| Fukushima, K | 1 |
| Urade, T | 1 |
| So, S | 1 |
| Shinzeki, M | 1 |
| Terashima, K | 1 |
| Fujii, O | 1 |
| Demizu, Y | 1 |
| Fuwa, N | 1 |
| Jiang, L | 1 |
| Lei, JY | 1 |
| Wang, WT | 1 |
| Yan, LN | 2 |
| Li, B | 2 |
| Wen, TF | 1 |
| Xu, MQ | 1 |
| Yang, JY | 2 |
| Wei, YG | 1 |
| Tsai, WL | 1 |
| Lai, KH | 4 |
| Liang, HL | 3 |
| Hsu, PI | 2 |
| Chan, HH | 1 |
| Chen, WC | 1 |
| Yu, HC | 2 |
| Tsay, FW | 1 |
| Wang, HM | 1 |
| Tsai, HC | 1 |
| Cheng, JS | 2 |
| Li, Z | 3 |
| Cai, Z | 1 |
| Dai, S | 1 |
| Deng, H | 1 |
| Ji, F | 1 |
| Xi, Q | 1 |
| Gao, N | 1 |
| Zhang, X | 3 |
| Zhang, B | 3 |
| Ye, W | 1 |
| Wu, J | 1 |
| Lin, CL | 1 |
| Chien, RN | 1 |
| Yeh, C | 1 |
| Hsu, CW | 1 |
| Chen, YC | 2 |
| Liu, B | 1 |
| Huang, JW | 1 |
| Li, Y | 2 |
| Hu, BS | 1 |
| He, X | 1 |
| Zhao, W | 1 |
| Zheng, YB | 1 |
| Lu, LG | 2 |
| Zuo, CH | 1 |
| Xia, M | 1 |
| Liu, JS | 1 |
| Qiu, XX | 1 |
| Lei, X | 1 |
| Xu, RC | 1 |
| Liu, HC | 1 |
| Li, JL | 1 |
| Li, YG | 1 |
| Li, QL | 1 |
| Xiao, H | 1 |
| Hong, Y | 1 |
| Wang, XH | 1 |
| Zhu, HZ | 1 |
| Wu, QF | 1 |
| Burns, M | 1 |
| Liang, Y | 1 |
| Feng, Q | 1 |
| Hong, J | 1 |
| Feng, F | 1 |
| Sang, Y | 1 |
| Hu, W | 1 |
| Xu, M | 1 |
| Peng, R | 1 |
| Kang, T | 1 |
| Bei, J | 1 |
| Zeng, Y | 1 |
| Luo, S | 1 |
| Gu, Y | 1 |
| Guo, P | 1 |
| Mukerabigwi, JF | 1 |
| Liu, M | 1 |
| Lei, S | 1 |
| Cao, Y | 2 |
| He, H | 2 |
| Huang, X | 2 |
| Laroia, ST | 1 |
| Morales, SA | 1 |
| Laroia, AT | 1 |
| Mouli, SK | 1 |
| Hickey, R | 1 |
| Thornburg, B | 1 |
| Sato, KT | 2 |
| Desai, K | 1 |
| Gabr, A | 1 |
| Kallini, JR | 1 |
| Niemeri, H | 1 |
| Kircher, S | 1 |
| Mulcahy, MF | 2 |
| Benson Iii, AB | 1 |
| Gupta, R | 1 |
| Salem, R | 4 |
| Lewandowski, RJ | 4 |
| Tang, C | 1 |
| Feng, W | 1 |
| Bao, Y | 1 |
| Dong, X | 1 |
| Dai, Y | 2 |
| Zheng, Y | 1 |
| Zhang, J | 2 |
| Oppermann, E | 1 |
| Qian, J | 2 |
| Imlau, U | 1 |
| Tran, A | 1 |
| Hamidavi, Y | 1 |
| Korkusuz, H | 1 |
| Bechstein, WO | 2 |
| Nour-Eldin, NE | 2 |
| Hammerstingl, R | 2 |
| Shelgikar, CS | 1 |
| Loehle, J | 1 |
| Scoggins, CR | 1 |
| McMasters, KM | 1 |
| Martin, RC | 1 |
| Ishida, K | 1 |
| Hirooka, M | 1 |
| Hiraoka, A | 1 |
| Kumagi, T | 1 |
| Uehara, T | 1 |
| Hiasa, Y | 1 |
| Horiike, N | 1 |
| Onji, M | 1 |
| Shiraishi, R | 1 |
| Yamasaki, T | 2 |
| Saeki, I | 1 |
| Okita, K | 1 |
| Yamaguchi, Y | 1 |
| Uchida, K | 1 |
| Terai, S | 1 |
| Sakaida, I | 1 |
| Leelawat, K | 1 |
| Laisupasin, P | 1 |
| Kiatdilokrut, A | 1 |
| Pongtongpool, T | 1 |
| Narong, S | 1 |
| Samkhumphim, N | 1 |
| Ket-Horm, S | 1 |
| Liang, SN | 1 |
| Liu, LL | 1 |
| Su, HY | 1 |
| Feng, B | 1 |
| Zhao, GS | 1 |
| Xu, K | 1 |
| Xiao, YP | 1 |
| Xiao, EH | 1 |
| Luo, JG | 1 |
| Bian, DJ | 1 |
| Li, MQ | 1 |
| He, Z | 1 |
| Shang, QL | 1 |
| Liang, B | 1 |
| Guan, HG | 2 |
| Xue, WJ | 2 |
| Qian, HX | 2 |
| Zhou, XJ | 2 |
| Qin, L | 2 |
| Lan, J | 1 |
| Li, SL | 1 |
| Huang, ZN | 1 |
| Hsieh, HH | 1 |
| Yu, WC | 1 |
| Tzeng, WY | 1 |
| Lee, GY | 1 |
| Chen, YP | 1 |
| Chang, CY | 1 |
| Chuu, JJ | 1 |
| Sun, HW | 1 |
| Chen, LH | 1 |
| Wei, CJ | 1 |
| Zheng, XK | 1 |
| Li, QS | 1 |
| Guan, J | 1 |
| Sun, B | 1 |
| Luo, M | 1 |
| Lu, Z | 1 |
| Meng, Y | 1 |
| Wu, S | 1 |
| Wu, M | 1 |
| Kumari, R | 1 |
| Sharma, A | 1 |
| Ajay, AK | 1 |
| Bhat, MK | 1 |
| Gomes, AS | 1 |
| Rosove, MH | 1 |
| Rosen, PJ | 1 |
| Amado, RG | 1 |
| Sayre, JW | 1 |
| Monteleone, PA | 1 |
| Busuttil, RW | 1 |
| Takayasu, K | 2 |
| Arii, S | 1 |
| Ikai, I | 1 |
| Kudo, M | 2 |
| Matsuyama, Y | 1 |
| Kojiro, M | 1 |
| Makuuchi, M | 1 |
| Hiramine, Y | 1 |
| Imamura, Y | 1 |
| Uto, H | 1 |
| Baba, Y | 1 |
| Hiwaki, T | 1 |
| Sho, Y | 1 |
| Tahara, K | 1 |
| Tsubouchi, H | 1 |
| Gaba, RC | 3 |
| Carroll, JJ | 1 |
| Bui, JT | 1 |
| Carrillo, TC | 1 |
| Knuttinen, MG | 1 |
| Owens, CA | 1 |
| Zhong, X | 1 |
| Xiong, M | 1 |
| Meng, X | 1 |
| Gong, R | 1 |
| Dufour, JF | 1 |
| Hoppe, H | 1 |
| Heim, MH | 1 |
| Helbling, B | 1 |
| Maurhofer, O | 1 |
| Szucs-Farkas, Z | 1 |
| Kickuth, R | 1 |
| Borner, M | 1 |
| Candinas, D | 1 |
| Saar, B | 1 |
| Chuma, M | 1 |
| Kusunoki, N | 1 |
| Tsuchida, S | 2 |
| Takahashi, M | 3 |
| Tsugawa, D | 1 |
| Awazu, M | 1 |
| Kataoka, Y | 1 |
| Hori, Y | 1 |
| Kuroda, D | 1 |
| Sakamoto, H | 1 |
| Amikura, K | 1 |
| Tanaka, Y | 2 |
| Nishimura, Y | 3 |
| Kawashima, Y | 1 |
| Yatsuoka, T | 1 |
| Yamagata, Y | 1 |
| Yamaura, T | 1 |
| Yokoyama, Y | 1 |
| Akiyama, H | 1 |
| Nakajima, T | 2 |
| Chung, GE | 1 |
| Kim, HY | 1 |
| Hwang, SY | 1 |
| Kim, JS | 1 |
| Chung, JW | 2 |
| Choi, JW | 1 |
| Kim, HC | 1 |
| Kim, JD | 1 |
| Kim, GM | 1 |
| Lee, IJ | 1 |
| Jae, HJ | 1 |
| Park, JH | 1 |
| Hu, B | 1 |
| Tu, YY | 1 |
| Yan, GP | 1 |
| Zhuo, RX | 1 |
| Bottle, SE | 1 |
| Wu, Y | 4 |
| Fan, CL | 1 |
| Duan, YJ | 1 |
| Ueno, M | 1 |
| Uchiyama, K | 1 |
| Ozawa, S | 1 |
| Hayami, S | 1 |
| Shigekawa, Y | 1 |
| Tani, M | 1 |
| Yamaue, H | 1 |
| Chen, D | 1 |
| Zhao, P | 1 |
| Liu, L | 1 |
| Qi, C | 1 |
| Liu, Y | 2 |
| Wang, Q | 2 |
| Chen, S | 1 |
| Yuan, Z | 1 |
| Ye, XD | 1 |
| Dong, S | 1 |
| Xu, LC | 1 |
| Xiao, XS | 1 |
| Choi, SY | 1 |
| Shen, YN | 1 |
| Woo, SR | 1 |
| Yun, M | 1 |
| Park, JE | 1 |
| Ju, YJ | 1 |
| Jeong, J | 1 |
| Shin, HJ | 1 |
| Joo, HY | 1 |
| Park, ER | 1 |
| Lee, JK | 1 |
| Kim, SH | 1 |
| Cho, MH | 1 |
| Kong, IS | 1 |
| Lee, KH | 1 |
| Hsieh, MY | 2 |
| Lin, ZY | 3 |
| Chen, SH | 2 |
| Chuang, WL | 2 |
| Antoch, G | 1 |
| Roelle, G | 1 |
| Ladd, SC | 1 |
| Kuehl, H | 1 |
| Heusner, TA | 1 |
| Sotiropoulos, GC | 1 |
| Hilgard, P | 1 |
| Forsting, M | 1 |
| Verhagen, R | 1 |
| Lin, CI | 1 |
| Huang, CF | 1 |
| Miyayama, S | 2 |
| Yamashiro, M | 1 |
| Shibata, Y | 1 |
| Hashimoto, M | 2 |
| Yoshida, M | 2 |
| Tsuji, K | 1 |
| Toshima, F | 1 |
| Matsui, O | 5 |
| Farshid, P | 1 |
| Lehnert, T | 2 |
| Engels, KS | 1 |
| Morse, MA | 1 |
| Hanks, BA | 1 |
| Suhocki, P | 1 |
| Doan, PL | 1 |
| Liu, EA | 1 |
| Frost, P | 1 |
| Bernard, SA | 1 |
| Tsai, A | 1 |
| Moore, DT | 1 |
| O'Neil, BH | 1 |
| Sahara, S | 2 |
| Kawai, N | 1 |
| Sato, M | 8 |
| Tanaka, T | 3 |
| Ikoma, A | 1 |
| Nakata, K | 2 |
| Sanda, H | 1 |
| Minamiguchi, H | 1 |
| Nakai, M | 2 |
| Shirai, S | 1 |
| Sonomura, T | 1 |
| Jin, B | 1 |
| Wang, D | 3 |
| Ragin, AB | 1 |
| Larson, AC | 3 |
| Chen, Y | 2 |
| Ge, N | 1 |
| Zhang, L | 1 |
| Xie, X | 2 |
| Chen, R | 1 |
| Xia, J | 1 |
| Gan, Y | 1 |
| Ren, Z | 1 |
| Ye, S | 1 |
| Inuzuka, T | 1 |
| Nakajima, J | 1 |
| Matsuda, F | 1 |
| Henmi, S | 1 |
| Hatamaru, K | 1 |
| Li, H | 1 |
| Hu, Y | 1 |
| Li, N | 2 |
| Zhou, Y | 1 |
| Georgiades, C | 1 |
| Geschwind, JF | 1 |
| Harrison, N | 1 |
| Hines-Peralta, A | 1 |
| Liapi, E | 1 |
| Hong, K | 1 |
| Wu, Z | 1 |
| Kamel, I | 1 |
| Frangakis, C | 1 |
| Peng, JW | 1 |
| Lin, GN | 1 |
| Xiao, JJ | 1 |
| Jiang, XM | 1 |
| Seki, H | 1 |
| Ozaki, T | 2 |
| Ooi, H | 1 |
| Fang, WQ | 1 |
| Guo, RP | 1 |
| Chen, MS | 1 |
| Luo, J | 1 |
| Xu, L | 1 |
| Zou, RH | 1 |
| Lin, XJ | 1 |
| Zhang, YQ | 3 |
| Arimoto, A | 1 |
| Wakasa, T | 1 |
| Zhuo, L | 1 |
| Liu, J | 1 |
| Wang, B | 1 |
| Gao, M | 1 |
| Huang, A | 1 |
| Petruzzi, NJ | 1 |
| Frangos, AJ | 1 |
| Fenkel, JM | 1 |
| Herrine, SK | 1 |
| Hann, HW | 1 |
| Rossi, S | 1 |
| Rosato, EL | 1 |
| Eschelman, DJ | 1 |
| Gonsalves, CF | 1 |
| Lu, W | 1 |
| Li, YH | 2 |
| He, XF | 1 |
| Zeng, QL | 1 |
| Qiu, YR | 1 |
| Masutani, S | 2 |
| Shimizu, J | 1 |
| Tatsuta, M | 1 |
| Katoh, H | 2 |
| Kitani, K | 1 |
| Esumi, K | 1 |
| Masuda, N | 1 |
| Imamura, H | 1 |
| Ishida, H | 2 |
| Furukawa, H | 2 |
| Onishi, H | 1 |
| Tsuda, K | 2 |
| Inoue, Y | 2 |
| Tomotsu, K | 2 |
| Usui, T | 2 |
| Truebenbach, J | 1 |
| Graepler, F | 1 |
| Pereira, P | 1 |
| Huppert, P | 1 |
| Eul, T | 1 |
| Wiemann, G | 1 |
| Claussen, C | 1 |
| Yi, J | 2 |
| Liao, X | 2 |
| Yang, Z | 2 |
| Xu, F | 1 |
| Song, DQ | 1 |
| Zhen, YS | 2 |
| Liao, ZY | 1 |
| Zhang, SH | 1 |
| Katsumata, K | 1 |
| Tomioka, H | 1 |
| Sumi, T | 1 |
| Takagi, M | 1 |
| Kato, F | 1 |
| Suzuki, Y | 3 |
| Aoki, T | 1 |
| Koyanagi, Y | 1 |
| Ahrar, K | 2 |
| Gupta, S | 1 |
| Wang, CS | 1 |
| Liao, LY | 1 |
| Wang, CK | 1 |
| Shih, LS | 1 |
| Chen, RC | 2 |
| Chen, PH | 1 |
| Yu, J | 1 |
| Wang, L | 1 |
| Zhou, T | 1 |
| Zhai, L | 1 |
| Xing, L | 1 |
| USUBUCHI, I | 1 |
| KAGEYAMA, T | 1 |
| KOIZUMI, A | 2 |
| YOSHIDA, K | 1 |
| TAKAHASHI, T | 5 |
| YAMAGUCHI, I | 1 |
| MAJIMA, S | 1 |
| HAGIHARA, K | 1 |
| HIRONO, I | 1 |
| KOJIMA, K | 2 |
| KACHI, H | 1 |
| OHASHI, A | 1 |
| SASAOKA, I | 1 |
| KOSHIURA, R | 1 |
| KOSHIMURA, S | 1 |
| BANDO, Y | 1 |
| Deng, W | 1 |
| Tian, G | 1 |
| Mok, KT | 1 |
| Wang, BW | 1 |
| Lo, GH | 2 |
| Liu, SI | 1 |
| Chou, NH | 1 |
| Tsai, CC | 1 |
| Chen, IS | 1 |
| Yeh, MH | 1 |
| Pan, DY | 1 |
| Qiao, JG | 1 |
| Chen, JW | 1 |
| Huo, YC | 1 |
| Zhou, YK | 1 |
| Shi, HA | 1 |
| Nagano, H | 2 |
| Sakon, M | 3 |
| Monden, M | 4 |
| Yang, XD | 1 |
| Tang, DN | 1 |
| Wang, J | 4 |
| Cao, DL | 1 |
| Chen, XM | 1 |
| Luo, PF | 2 |
| Lin, HH | 1 |
| Zhou, ZJ | 1 |
| Shao, PJ | 1 |
| Fu, L | 1 |
| Li, WK | 1 |
| Taki, K | 1 |
| Minami, T | 1 |
| Ito, C | 1 |
| Shinmura, R | 1 |
| Takamatsu, S | 1 |
| Kobayashi, M | 8 |
| Notsumata, K | 1 |
| Toya, D | 1 |
| Tanaka, N | 2 |
| Kozaka, K | 1 |
| Cheng, SQ | 1 |
| Wu, MC | 1 |
| Shen, F | 1 |
| Yang, JH | 1 |
| Cong, WM | 1 |
| Zhao, YX | 1 |
| Wang, PJ | 1 |
| Newman, RA | 1 |
| Pang, J | 1 |
| Vijjeswarapu, MK | 1 |
| Wallace, MJ | 1 |
| Wright, KC | 1 |
| Ren, H | 1 |
| Cheng, L | 1 |
| Fundakowski, CE | 2 |
| Lisker-Melman, M | 2 |
| Crippin, JS | 2 |
| Pilgram, TK | 2 |
| Chapman, W | 1 |
| Darcy, MD | 2 |
| Hirakata, A | 1 |
| Kato, S | 4 |
| Kawano, Y | 1 |
| Mineta, S | 1 |
| Taniai, N | 1 |
| Mamada, Y | 1 |
| Yokomuro, S | 1 |
| Yoshida, H | 1 |
| Akimaru, K | 2 |
| Tajiri, T | 3 |
| Li, HH | 1 |
| Duan, ZH | 1 |
| Zhang, HW | 1 |
| Chen, JS | 1 |
| Yao, L | 1 |
| Wang, FS | 1 |
| Lei, ZY | 1 |
| Li, WL | 1 |
| Liu, JC | 1 |
| Tang, ZR | 1 |
| Zhou, GD | 1 |
| Liu, MZ | 1 |
| Wang, XS | 1 |
| Cai, L | 1 |
| Gu, MF | 1 |
| Liu, H | 1 |
| Cui, NJ | 1 |
| Li, GH | 1 |
| Li, JQ | 2 |
| Asahara, S | 1 |
| Ikari, T | 1 |
| Kamei, A | 1 |
| Sato, E | 1 |
| Takano, K | 1 |
| Fujita, N | 1 |
| Shimizu, M | 2 |
| Fujita, R | 1 |
| Hwang, JY | 1 |
| Jang, BK | 1 |
| Kwon, KM | 1 |
| Chung, WJ | 1 |
| Park, KS | 1 |
| Cho, KB | 1 |
| Hwang, JS | 1 |
| Ahn, SH | 1 |
| Kim, GC | 1 |
| Kim, YH | 1 |
| Choi, JS | 1 |
| Kwon, JH | 1 |
| Li, CP | 1 |
| Chao, Y | 1 |
| Lin, CP | 1 |
| Lin, CK | 1 |
| Chen, HH | 1 |
| Lo, CC | 1 |
| Tseng, HH | 1 |
| Herber, S | 2 |
| Schneider, J | 3 |
| Brecher, B | 1 |
| Höhler, T | 1 |
| Thelen, M | 1 |
| Otto, G | 3 |
| Pitton, MB | 3 |
| Haruno, M | 1 |
| Shimamura, R | 1 |
| Ogawa, Y | 1 |
| Tanaka, H | 2 |
| Sakai, K | 3 |
| Araki, K | 1 |
| Shiraki, T | 1 |
| Higashi, K | 1 |
| Maeda, M | 1 |
| Takeuchi, N | 1 |
| Kimura, M | 3 |
| Terada, M | 1 |
| Ge, NL | 1 |
| Ren, ZG | 1 |
| Ye, SL | 1 |
| Xia, JL | 1 |
| Gan, YH | 1 |
| Li, LX | 1 |
| Shen, YF | 1 |
| Tang, ZY | 2 |
| Lii, JM | 1 |
| Chen, WT | 1 |
| Tu, HY | 1 |
| Chiang, LC | 1 |
| Gao, WB | 1 |
| Han, JD | 1 |
| Du, M | 1 |
| Chapman, WC | 1 |
| Shao, RH | 1 |
| Ye, HY | 1 |
| Wang, ZQ | 1 |
| Wang, ZP | 1 |
| Yamaura, G | 1 |
| Yoshioka, T | 4 |
| Fukuda, H | 1 |
| Yamaguchi, K | 2 |
| Suzuki, M | 2 |
| Furumoto, S | 1 |
| Iwata, R | 1 |
| Ishioka, C | 1 |
| Zangos, S | 3 |
| Balzer, JO | 3 |
| Straub, R | 1 |
| Herzog, C | 1 |
| Heller, M | 1 |
| Thalhammer, A | 2 |
| Mack, MG | 2 |
| Sun, Y | 1 |
| Cui, YL | 1 |
| Juzi, JT | 1 |
| Qian, BY | 1 |
| Hao, XS | 1 |
| Ling, MT | 1 |
| Wong, YC | 1 |
| Wang, X | 1 |
| Bessard, A | 1 |
| Frémin, C | 1 |
| Ezan, F | 1 |
| Coutant, A | 1 |
| Baffet, G | 1 |
| Zhao, QZ | 1 |
| Dou, KF | 1 |
| Gu, T | 1 |
| Li, CX | 1 |
| Feng, Y | 1 |
| Li, CH | 1 |
| Li, CF | 1 |
| Chen, YB | 1 |
| Yan, ML | 1 |
| Gong, JP | 1 |
| Xia, RP | 1 |
| Liu, LX | 1 |
| Lu, SC | 1 |
| Zhang, JG | 1 |
| Zeng, DB | 1 |
| Xie, JG | 1 |
| Zhang, JH | 2 |
| Hao, FR | 1 |
| Kong, ZL | 1 |
| Shen, ZF | 1 |
| Jin, YZ | 1 |
| Li, P | 1 |
| Wang, ZW | 1 |
| Pitton, M | 1 |
| Mönch, C | 1 |
| Manzl, N | 2 |
| Kummer, I | 2 |
| Kanzler, S | 1 |
| Schuchmann, M | 2 |
| Junginger, T | 2 |
| Düber, C | 2 |
| Liedtke, C | 1 |
| Lambertz, D | 1 |
| Schnepel, N | 1 |
| Trautwein, C | 1 |
| Nabil, M | 1 |
| Rao, P | 1 |
| Zeuzem, S | 1 |
| Abdelkader, A | 1 |
| Zhou, ZX | 1 |
| Zhang, LJ | 1 |
| Huang, XH | 1 |
| Liu, ZJ | 1 |
| Atassi, B | 1 |
| Ryu, RK | 2 |
| Nemcek, AA | 1 |
| Kulik, LM | 1 |
| Miller, FH | 2 |
| Herber, SC | 1 |
| Tepper, J | 1 |
| Ibrahim, S | 1 |
| Kulik, L | 1 |
| Mulcahy, M | 1 |
| Sato, K | 1 |
| Wu, XY | 1 |
| Qian, JJ | 1 |
| Lin, Y | 1 |
| Zheng, MH | 1 |
| Kajiya, Y | 3 |
| Kobayashi, H | 9 |
| Hidaka, H | 4 |
| Onohara, S | 1 |
| Maeda, T | 4 |
| Ikeda, K | 10 |
| Inoue, H | 7 |
| Oyama, T | 2 |
| Sonoda, T | 3 |
| Shinohara, S | 4 |
| Akiharu, W | 1 |
| Higashi, T | 2 |
| Nakatsukasa, H | 1 |
| Fujiwara, M | 1 |
| Shiota, T | 1 |
| Yamauchi, Y | 1 |
| Ito, T | 2 |
| Yamamoto, H | 1 |
| Nagashima, H | 1 |
| Hirai, K | 11 |
| Kumagai, M | 2 |
| Kawazoe, Y | 3 |
| Okubo, K | 1 |
| Yamaguchi, G | 1 |
| Miura, T | 6 |
| Nagasaki, Y | 1 |
| Abe, M | 6 |
| Tanikawa, K | 9 |
| Ando, K | 1 |
| Patt, YZ | 1 |
| Chuang, VP | 2 |
| Wallace, S | 1 |
| Benjamin, RS | 1 |
| Fuqua, R | 1 |
| Mavligit, GM | 1 |
| Ohya, T | 1 |
| Kikuchi, S | 1 |
| Takagi, H | 5 |
| Morimoto, T | 1 |
| Yasue, M | 1 |
| Ochiai, E | 1 |
| Yamada, E | 1 |
| Ashizawa, T | 1 |
| Kido, C | 2 |
| Sheen, MC | 1 |
| Huang, TJ | 1 |
| Sheen, PC | 1 |
| Ho, YH | 1 |
| Sheu, HM | 1 |
| Ou, SC | 1 |
| Wu, CC | 1 |
| Kato, T | 2 |
| Tamakawa, Y | 1 |
| Unno, K | 1 |
| Kawabata, M | 2 |
| Takashima, S | 5 |
| Mitsuzane, K | 1 |
| Maeda, C | 1 |
| Hamachi, J | 1 |
| Nomura, S | 2 |
| Toshiyuki, M | 1 |
| Kobayashi, N | 3 |
| Ohnishi, K | 5 |
| Tsuchiya, S | 2 |
| Nakayama, T | 3 |
| Hiyama, Y | 2 |
| Iwama, S | 2 |
| Goto, N | 2 |
| Takashi, M | 2 |
| Ohtsuki, T | 2 |
| Kono, K | 1 |
| Nakajima, Y | 4 |
| Yamada, R | 4 |
| Nakatsuka, H | 5 |
| Nakamura, K | 5 |
| Shibakiri, I | 1 |
| Itami, M | 1 |
| Minakuchi, K | 3 |
| Yamaguchi, S | 1 |
| Onoyama, Y | 3 |
| Okuda, K | 6 |
| Monna, T | 2 |
| Kanno, T | 3 |
| Marumo, T | 1 |
| Harihara, S | 2 |
| Kuroki, T | 1 |
| Yamamoto, S | 3 |
| Ohto, M | 1 |
| Tsuchiya, Y | 1 |
| Saisho, H | 1 |
| Kimura, K | 1 |
| Morita, M | 1 |
| Mishima, A | 1 |
| Saito, M | 3 |
| Hatano, H | 1 |
| Nomura, F | 2 |
| Otsuki, T | 1 |
| Kohno, K | 2 |
| Itoh, J | 1 |
| Nakagawa, H | 3 |
| Sasaki, H | 1 |
| Katoh, T | 1 |
| Fujii, M | 3 |
| Murakami, N | 2 |
| Matsuka, Y | 2 |
| Ejiri, T | 2 |
| Asano, K | 2 |
| Miyamoto, H | 2 |
| Ogawa, M | 1 |
| Inagaki, J | 1 |
| Horikoshi, N | 1 |
| Ezaki, K | 1 |
| Inoue, K | 1 |
| Nagata, T | 1 |
| Aiba, K | 1 |
| Domyo, M | 1 |
| Himori, T | 1 |
| Ujiie, S | 1 |
| Mimata, Y | 1 |
| Sugiyama, Z | 1 |
| Wakui, A | 1 |
| Okamura, J | 3 |
| Kuroda, C | 2 |
| Sakurai, M | 2 |
| Nishimine, K | 2 |
| Uchida, H | 3 |
| Matsuo, N | 2 |
| Sakaguchi, H | 3 |
| Hirohashi, S | 2 |
| Guo, Q | 1 |
| Ohishi, H | 3 |
| Nagano, N | 2 |
| Higuchi, T | 1 |
| Kikuchi, M | 1 |
| Okazaki, M | 1 |
| Konno, T | 3 |
| Kai, Y | 1 |
| Yamashita, R | 1 |
| Nagamitsu, A | 1 |
| Cheng, LF | 1 |
| Li, L | 2 |
| Wang, HZ | 1 |
| Lygidakis, NJ | 1 |
| Kosmidis, P | 1 |
| Ziras, N | 1 |
| Parissis, J | 1 |
| Kyparidou, E | 1 |
| Nakashima, K | 5 |
| Aramaki, M | 4 |
| Kawano, K | 2 |
| Yoshida, T | 6 |
| Kim, YI | 5 |
| Kitano, S | 2 |
| Morris, TJ | 1 |
| Palm, SL | 1 |
| Furcht, LL | 1 |
| Buchwald, H | 1 |
| Khan, KN | 1 |
| Shima, M | 1 |
| Kusumoto, Y | 1 |
| Ishii, N | 1 |
| Koji, T | 1 |
| Nagataki, S | 1 |
| Shiina, S | 1 |
| Tagawa, K | 1 |
| Niwa, Y | 1 |
| Unuma, T | 1 |
| Komatsu, Y | 1 |
| Yoshiura, K | 1 |
| Hamada, E | 2 |
| Shiratori, Y | 1 |
| Terano, A | 1 |
| Kelm, C | 1 |
| Henneking, K | 1 |
| Zimmermann, T | 1 |
| Vollerthun, M | 1 |
| Padberg, W | 1 |
| Salvadori, DM | 1 |
| Ribeiro, LR | 1 |
| Natarajan, AT | 1 |
| Kaneko, Y | 1 |
| Tsukamoto, A | 1 |
| Su, J | 1 |
| Zhen, YC | 1 |
| Qi, CQ | 1 |
| Hu, JL | 1 |
| Kanematsu, M | 1 |
| Lorenz, M | 2 |
| Liermann, D | 1 |
| Staib-Sebler, E | 1 |
| Gog, C | 1 |
| Encke, A | 1 |
| Kollath, J | 1 |
| Wei, C | 1 |
| Liu, KD | 1 |
| Zhang, WZ | 1 |
| Gattoni, F | 1 |
| Pompili, GG | 1 |
| Dova, S | 1 |
| Baldini, U | 1 |
| Raiteri, R | 1 |
| Sacrini, A | 1 |
| Uslenghi, CM | 1 |
| Aso, N | 1 |
| Matsunaga, N | 1 |
| Fukuda, T | 1 |
| Sakamoto, I | 1 |
| Ashizawa, K | 1 |
| Aikawa, H | 3 |
| Isomoto, I | 1 |
| Hayashi, K | 1 |
| Fukushima, T | 1 |
| Morikawa, M | 1 |
| Motohara, T | 1 |
| Ozawa, Z | 1 |
| Morita, S | 2 |
| Maruhashi, Y | 1 |
| Hirose, S | 1 |
| Satomura, Y | 1 |
| Hayakawa, Y | 1 |
| Ohta, H | 1 |
| Demachi, H | 1 |
| Miwa, A | 1 |
| Nakanuma, Y | 1 |
| Marchiori, L | 1 |
| Mansueto, GC | 1 |
| Nifosi, F | 1 |
| Bortolasi, L | 1 |
| Dal Dosso, I | 1 |
| Facci, E | 1 |
| Perus, G | 1 |
| Nicoli, N | 1 |
| Kaibara, A | 1 |
| Yoshida, S | 1 |
| Yamasaki, K | 1 |
| Ishibashi, N | 1 |
| Kakegawa, T | 1 |
| Izumi, R | 4 |
| Shimizu, K | 6 |
| Iyobe, T | 3 |
| Ii, T | 2 |
| Yagi, M | 2 |
| Nonomura, A | 1 |
| Miyazaki, I | 3 |
| Lu, CD | 1 |
| Qi, YG | 1 |
| Peng, SY | 1 |
| Sugimoto, M | 3 |
| Iwamiya, T | 2 |
| Sawada, S | 3 |
| Ohta, Y | 2 |
| Yasui, M | 1 |
| Nonami, T | 2 |
| Kurokawa, T | 1 |
| Nakao, A | 2 |
| Harada, A | 2 |
| Hashimoto, S | 1 |
| Kajikawa, M | 1 |
| Hiraoka, E | 1 |
| Oi, H | 2 |
| Kim, T | 2 |
| Kishimoto, H | 1 |
| Matsushita, M | 1 |
| Tateishi, H | 1 |
| Wen, YJ | 1 |
| Watanabe, K | 2 |
| Masuda, S | 1 |
| Mokode, Y | 1 |
| Ishioh, M | 1 |
| Oba, H | 1 |
| Shibuya, T | 1 |
| Shoji, T | 1 |
| Nakagawa, T | 1 |
| Xu, HB | 1 |
| Yan, XQ | 1 |
| Itsubo, M | 1 |
| Miyazono, N | 3 |
| Kanetsuki, I | 4 |
| Tanaka, D | 1 |
| Fukukura, Y | 1 |
| Tsuchimochi, S | 1 |
| Hokotate, H | 1 |
| Ida, K | 1 |
| Miyake, S | 1 |
| Satake, M | 2 |
| Nishida, H | 3 |
| Nakajo, M | 5 |
| Kantoh, T | 1 |
| Abo, H | 1 |
| Katsumori, T | 1 |
| Fujita, M | 1 |
| Satoh, O | 1 |
| Kohda, Y | 1 |
| Nakano, Y | 1 |
| Akimoto, K | 1 |
| Ohno, K | 1 |
| Mäkelä, J | 1 |
| Tikkakoski, T | 1 |
| Leinonen, A | 1 |
| Siniluoto, T | 1 |
| Karttunen, A | 1 |
| Kairaluoma, MI | 1 |
| Suzuki, K | 4 |
| Itano, S | 1 |
| Kajiwara, M | 1 |
| Ijuin, H | 1 |
| Ban, S | 1 |
| Sakata, K | 2 |
| Ono, N | 2 |
| Noguchi, H | 5 |
| Sakai, T | 7 |
| Laget, M | 1 |
| Guiraud-Dauriac, H | 1 |
| de Méo, MP | 1 |
| di Giorgio, C | 1 |
| Roth, E | 1 |
| Duménil, G | 1 |
| Yamashita, F | 1 |
| Satomura, S | 1 |
| Yao, KS | 1 |
| Godwin, AK | 1 |
| Johnson, C | 1 |
| O'Dwyer, PJ | 1 |
| Onda, M | 2 |
| Tokunaga, A | 1 |
| Yoshiyuki, T | 1 |
| Matsukura, N | 1 |
| Kim, DY | 1 |
| Yamashita, K | 10 |
| Soini, Y | 1 |
| Virkajärvi, N | 1 |
| Raunio, H | 1 |
| Pääkkö, P | 1 |
| Link, KH | 1 |
| Pillasch, J | 1 |
| Weindel, M | 1 |
| Leder, G | 1 |
| Beger, HG | 1 |
| Iwasaki, T | 2 |
| Maeda, I | 1 |
| Sugimoto, T | 1 |
| Kanamaru, T | 1 |
| Kuroda, Y | 2 |
| Saitoh, Y | 1 |
| Kawahara, N | 1 |
| Yokomizo, A | 1 |
| Nanri, H | 1 |
| Ono, M | 1 |
| Wada, M | 1 |
| Takenaka, K | 1 |
| Sugimachi, K | 5 |
| Kuwano, M | 1 |
| Belli, L | 1 |
| Magistretti, G | 1 |
| Puricelli, GP | 1 |
| Damiani, G | 1 |
| Colombo, E | 1 |
| Cornalba, GP | 1 |
| Yang, EB | 1 |
| Tang, WY | 1 |
| Zhang, K | 1 |
| Cheng, LY | 1 |
| Mack, PO | 1 |
| Kogawa, T | 1 |
| Maeda, S | 1 |
| Yoshii, T | 1 |
| Kokawa, A | 1 |
| Yamamura, H | 1 |
| Yamamoto, K | 1 |
| Ikeuchi, T | 1 |
| Tanaka, K | 3 |
| Zhou, D | 1 |
| Kusano, S | 2 |
| Katayama, M | 1 |
| Uematsu, M | 1 |
| Kaji, T | 1 |
| Kosuda, S | 1 |
| Endo, T | 1 |
| Ishii, K | 3 |
| An, M | 1 |
| Matsumoto, Y | 1 |
| Terakado, H | 1 |
| Murata, M | 2 |
| Takagi, S | 1 |
| Ikawa, M | 1 |
| Nakasato, S | 1 |
| Ihnat, MA | 1 |
| Lariviere, JP | 1 |
| Warren, AJ | 1 |
| La Ronde, N | 1 |
| Blaxall, JR | 1 |
| Pierre, KM | 1 |
| Turpie, BW | 1 |
| Hamilton, JW | 1 |
| Schrader, TJ | 1 |
| Castañeda, F | 1 |
| Kinne, RK | 1 |
| Sohara, N | 1 |
| Abe, T | 3 |
| Hashimoto, Y | 1 |
| Kojima, A | 1 |
| Takahashi, H | 1 |
| Nagamine, T | 2 |
| Mori, M | 1 |
| Solomon, B | 1 |
| Soulen, MC | 1 |
| Baum, RA | 1 |
| Haskal, ZJ | 1 |
| Shlansky-Goldberg, RD | 1 |
| Cope, C | 1 |
| Seno, H | 1 |
| Ito, K | 1 |
| Nakajima, N | 2 |
| Chiba, T | 1 |
| Kashima, Y | 1 |
| Miyazaki, M | 3 |
| Ito, H | 1 |
| Kaiho, T | 2 |
| Nakagawa, K | 1 |
| Ambiru, S | 1 |
| Shimizu, H | 1 |
| Furuya, S | 1 |
| Kumada, T | 1 |
| Nakano, S | 1 |
| Sone, Y | 1 |
| Kiriyama, S | 1 |
| Hisanaga, Y | 1 |
| Rikitoku, T | 1 |
| Tamoto, A | 1 |
| Honda, T | 1 |
| Acunaş, B | 2 |
| Rozanes, I | 2 |
| Ueno, K | 2 |
| Huang, YH | 1 |
| Wu, JC | 1 |
| Lui, WY | 2 |
| Chau, GY | 1 |
| Tsay, SH | 1 |
| Chiang, JH | 2 |
| King, KL | 1 |
| Huo, TI | 1 |
| Chang, FY | 1 |
| Lee, SD | 3 |
| Kakumu, S | 1 |
| Ito, S | 1 |
| Ishikawa, T | 1 |
| Mita, Y | 1 |
| Tagaya, T | 1 |
| Fukuzawa, Y | 1 |
| Yoshioka, K | 1 |
| Kok, LD | 1 |
| Wong, YP | 1 |
| Wu, TW | 1 |
| Chan, HC | 1 |
| Kwok, TT | 1 |
| Fung, KP | 1 |
| Takayasu, Y | 3 |
| Ikeda, J | 1 |
| Takamatsu, M | 1 |
| Sendou, H | 1 |
| Niinobu, T | 1 |
| Shibata, T | 1 |
| Fukushima, Y | 1 |
| Kitada, M | 1 |
| Tukahara, Y | 1 |
| Hata, S | 1 |
| Hayashida, H | 1 |
| Fuzita, J | 1 |
| Takahashi, Y | 1 |
| Suzuki, R | 1 |
| Shimano, T | 1 |
| Takami, M | 1 |
| Ishida, T | 1 |
| Zhou, J | 1 |
| Cheng, SC | 1 |
| Luo, D | 1 |
| Xie, Y | 1 |
| Chia-Hsien Cheng, J | 1 |
| Cheng, SH | 1 |
| Lin, YM | 1 |
| Cheng, TI | 1 |
| Yang, PS | 1 |
| Jian, JJ | 1 |
| You, DL | 1 |
| Horng, CF | 1 |
| Huang, AT | 1 |
| Gores, GJ | 1 |
| Gille, T | 1 |
| Engelmann, K | 1 |
| Woitaschek, D | 1 |
| Poyanli, A | 1 |
| Sencer, S | 1 |
| Kim, YC | 1 |
| Koh, JT | 1 |
| Shin, BA | 1 |
| Ahn, KY | 1 |
| Choi, BK | 1 |
| Kim, CG | 1 |
| Kim, KK | 1 |
| Xu, C | 1 |
| Zheng, S | 1 |
| Achenbach, T | 1 |
| Seifert, JK | 1 |
| Schunk, K | 1 |
| Yang, S | 1 |
| Zhu, H | 1 |
| Matsuki, S | 1 |
| Matama, S | 1 |
| Shibata, H | 2 |
| Matsumoto, M | 1 |
| Nakayama, M | 1 |
| Kitagami, K | 1 |
| Fukui, H | 1 |
| Tsujii, T | 2 |
| Okamoto, Y | 1 |
| Nakano, H | 1 |
| Schilling, A | 1 |
| Gewiese, B | 1 |
| Berger, G | 1 |
| Boese-Landgraf, J | 1 |
| Fobbe, F | 1 |
| Stiller, D | 1 |
| Gallkowski, U | 1 |
| Wolf, KJ | 1 |
| Damascelli, B | 2 |
| Garbagnati, F | 1 |
| Marchianò, A | 2 |
| Salvetti, M | 1 |
| Di Tolla, G | 1 |
| Lanocita, R | 1 |
| Kitamura, T | 1 |
| Maruyama, T | 1 |
| Iwaki, Y | 1 |
| Kawano, T | 1 |
| Eto, T | 1 |
| Tamaki, N | 1 |
| Shimada, Y | 1 |
| Komura, K | 1 |
| Ishinoda, Y | 1 |
| Kitamura, M | 1 |
| Oiyong, G | 1 |
| Ohue, S | 2 |
| Phornphutkul, K | 1 |
| Handagoon, P | 1 |
| Sirivanichai, C | 1 |
| Senarat, S | 1 |
| Nakamura, H | 4 |
| Yamagata, M | 2 |
| Kanematsu, T | 4 |
| Matsumata, T | 3 |
| Utsunomiya, T | 3 |
| Ikeda, Y | 1 |
| Abe, K | 2 |
| Sugata, F | 2 |
| Takizawa, K | 2 |
| Yoshiba, M | 2 |
| Takagi, T | 2 |
| Kuniyasu, Y | 2 |
| Okada, K | 2 |
| Iwao, Y | 2 |
| Kiriyama, M | 1 |
| Iwasa, K | 1 |
| Masutani, H | 1 |
| Nakazaki, H | 1 |
| Kuramoto, S | 1 |
| Watanabe, M | 1 |
| Hanawa, S | 1 |
| Hasebe, Y | 1 |
| Yanagita, K | 1 |
| Yoshio, T | 1 |
| Komada, H | 1 |
| Yamamura, M | 1 |
| Kawaguchi, Y | 1 |
| Kwon, M | 1 |
| Uetsuji, S | 1 |
| Kamiyama, Y | 1 |
| Nakanishi, Y | 1 |
| Harima, K | 1 |
| Mitani, T | 1 |
| Murakami, T | 1 |
| Hashimoto, T | 2 |
| Nakanishi, K | 1 |
| Maeshima, S | 1 |
| Tomoda, K | 1 |
| Kozuka, T | 1 |
| Morioka, N | 1 |
| Tanigawa, N | 1 |
| Okuda, Y | 1 |
| Kawasaki, H | 1 |
| Yano, T | 2 |
| Otani, Y | 1 |
| Tsukui, M | 1 |
| Goto, K | 1 |
| Makuuchi, H | 1 |
| Tajima, T | 1 |
| Mitomi, T | 1 |
| Chen, X | 1 |
| Zhong, D | 1 |
| Tan, T | 1 |
| Yan, C | 1 |
| Kanai, T | 1 |
| Gotoh, M | 1 |
| Kobayashi, K | 2 |
| Umeshita, K | 1 |
| Dono, K | 1 |
| Mori, T | 2 |
| Takeda, M | 1 |
| Mizuguchi, N | 1 |
| Ohyama, Y | 1 |
| Suzuki, S | 1 |
| Itoh, M | 1 |
| Mukojima, T | 1 |
| Kumagai, T | 1 |
| Iwasaki, H | 1 |
| Tada, I | 2 |
| Mori, K | 1 |
| Takeyama, M | 1 |
| Kamiyama, T | 1 |
| Une, Y | 2 |
| Matsuoka, S | 1 |
| Nagabuchi, E | 1 |
| Gotoda, A | 1 |
| Uchino, J | 2 |
| Higashi, S | 1 |
| Katsumata, T | 1 |
| Fukai, S | 1 |
| Li, GQ | 1 |
| Sawada, Y | 1 |
| Iwamoto, S | 1 |
| Yurino, N | 1 |
| Fujii, S | 1 |
| Murai, N | 1 |
| Okuno, F | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Tanaka, S | 1 |
| Takashima, T | 1 |
| Shizumi, Y | 3 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Hironaka, T | 1 |
| Fujimoto, K | 1 |
| Takada, K | 1 |
| Mitsuhashi, T | 1 |
| Ichikawa, W | 1 |
| Nihei, Z | 1 |
| Sawai, S | 1 |
| Uetake, H | 1 |
| Yamashita, T | 1 |
| Kawamura, N | 1 |
| Shiraishi, T | 1 |
| Mishima, Y | 1 |
| Maehara, Y | 2 |
| Shirabe, K | 2 |
| Akazawa, K | 1 |
| Furui, S | 1 |
| Nakoa, N | 1 |
| Kamino, K | 1 |
| Miura, K | 1 |
| Hayashi, T | 1 |
| Ohnishi, M | 1 |
| Okamoto, E | 1 |
| Matsuda, H | 1 |
| Watanabe, T | 2 |
| Chuganji, Y | 1 |
| Matsuzaki, Y | 1 |
| Ebihara, T | 1 |
| Shoda, J | 1 |
| Nishi, M | 1 |
| Matsumoto, H | 1 |
| Koyama, S | 1 |
| Fukutomi, H | 1 |
| Osuga, T | 2 |
| Audisio, RA | 1 |
| Doci, R | 1 |
| Mazzaferro, V | 1 |
| Bellegotti, L | 1 |
| Tommasini, M | 1 |
| Montalto, F | 1 |
| Piva, A | 1 |
| DeFazio, C | 1 |
| Ikeya, S | 1 |
| Muramatsu, Y | 1 |
| Moriyama, N | 1 |
| Hasegawa, H | 2 |
| Niwa, M | 1 |
| Saito, Y | 2 |
| Ogoshi, K | 1 |
| Nashimoto, A | 1 |
| Kato, K | 1 |
| Akai, S | 1 |
| Isshiki, K | 1 |
| Kishimoto, W | 1 |
| Akaza, K | 1 |
| Yokoyama, H | 1 |
| Takehara, M | 1 |
| Tabuchi, Y | 1 |
| Kotake, M | 1 |
| Aoki, Y | 7 |
| Hiratuka, H | 1 |
| Majima, Y | 5 |
| Sasaki, Y | 1 |
| Imaoka, S | 1 |
| Ohashi, I | 1 |
| Ishikawa, O | 1 |
| Oohigashi, H | 1 |
| Yasuda, T | 1 |
| Fukuda, I | 1 |
| Fukushima, H | 1 |
| Shimada, M | 1 |
| Iwai, I | 1 |
| Fujimoto, T | 3 |
| Nakashima, O | 1 |
| Ohsawa, K | 1 |
| Goto, T | 1 |
| Chiba, S | 1 |
| Nakamura, Y | 1 |
| Kondoh, K | 1 |
| Sasaki, S | 1 |
| Sekine, K | 1 |
| Katayama, S | 1 |
| Moriai, O | 1 |
| Hatta, Y | 1 |
| Endo, Y | 1 |
| Sassa, T | 1 |
| Yoshikawa, N | 1 |
| Hirose, N | 1 |
| Funatomi, H | 1 |
| Taguchi, S | 1 |
| Fujimoto, S | 2 |
| Endoh, F | 3 |
| Takahashi, O | 1 |
| Okui, K | 2 |
| Morimoto, Y | 1 |
| Kikuno, M | 1 |
| Hiraki, Y | 2 |
| Toyohira, K | 1 |
| Ito, Y | 2 |
| Takano, S | 1 |
| Sakabe, T | 1 |
| Yamaguchi, T | 2 |
| Kamata, R | 1 |
| Okayasu, I | 1 |
| Hatakeyama, S | 1 |
| Yoshimatsu, S | 1 |
| Tsuruta, K | 1 |
| Kimula, Y | 1 |
| Muraoka, A | 1 |
| Tokiwa, T | 1 |
| Sato, J | 1 |
| Suyama, Y | 4 |
| Kitagawa, Y | 1 |
| Horishi, M | 2 |
| Yashige, H | 1 |
| Fujii, H | 4 |
| Miyoshi, M | 3 |
| Ikeda, N | 1 |
| Sue, K | 1 |
| Ukida, M | 1 |
| Okamoto, T | 1 |
| Ohsawa, T | 1 |
| Nouso, K | 1 |
| Watanabe, A | 1 |
| Tsuji, T | 1 |
| Hamada, H | 1 |
| Sasaki, F | 1 |
| Hata, Y | 1 |
| Sawada, H | 1 |
| Tamura, M | 1 |
| Sato, N | 1 |
| Saito, H | 1 |
| Yang, CF | 2 |
| Ho, YZ | 2 |
| Chang, JM | 2 |
| Chiang, RH | 1 |
| Tsai, YT | 2 |
| Liu, TJ | 1 |
| Chen, GH | 2 |
| Yoshimura, H | 1 |
| Matsui, T | 1 |
| Takaya, A | 1 |
| Cheirsilpa, A | 1 |
| Leelasethakul, S | 1 |
| Auethaveekiat, V | 1 |
| Maoleekulpriroj, S | 1 |
| Kangsumrit, N | 1 |
| Thanakaravit, P | 1 |
| Phanthumjida, P | 1 |
| Hasumura, S | 1 |
| Nagamori, S | 1 |
| Fujise, K | 1 |
| Homma, S | 1 |
| Sujino, H | 1 |
| Matsuura, T | 1 |
| Niiya, M | 1 |
| Kameda, H | 1 |
| Udagawa, I | 1 |
| Koshikawa, H | 1 |
| Itoh, H | 2 |
| Kanno, Y | 1 |
| Teramoto, O | 1 |
| Kimura, F | 1 |
| Matsumoto, J | 1 |
| Miyazono, K | 2 |
| Kubo, Y | 3 |
| Saitsu, H | 1 |
| Shiga, T | 1 |
| Noguchi, T | 1 |
| Nishimaki, K | 1 |
| Kajikawa, S | 1 |
| Horigome, N | 1 |
| Hanasaki, K | 1 |
| Adachi, W | 1 |
| Kinosita, T | 1 |
| Sodeyama, H | 1 |
| Kuroda, T | 1 |
| Iida, F | 1 |
| Ishibashi, T | 1 |
| Okajima, K | 1 |
| Isozaki, H | 1 |
| Nakata, E | 1 |
| Nishimura, J | 1 |
| Iga, C | 1 |
| Amioka, K | 1 |
| Tanimura, M | 1 |
| Hara, H | 1 |
| Haida, K | 2 |
| Mitarai, Y | 1 |
| Yabushita, K | 1 |
| Horichi, H | 1 |
| Kitabayashi, K | 1 |
| Tani, T | 1 |
| Urade, M | 1 |
| Segawa, M | 1 |
| Furuta, T | 1 |
| Yasumori, K | 1 |
| Masuda, K | 1 |
| Karube, H | 1 |
| Okabe, H | 1 |
| Okudaira, M | 1 |
| Tsuchiya, M | 1 |
| Hottenrott, C | 1 |
| Kobayashi, T | 1 |
| Araki, I | 1 |
| Shinagawa, T | 1 |
| Sekikawa, H | 1 |
| Noda, M | 1 |
| Soga, K | 2 |
| Turuya, T | 1 |
| Toshima, M | 1 |
| Shibasaki, K | 1 |
| Matugi, H | 1 |
| Kawai, C | 1 |
| Asakura, H | 1 |
| Miyamoto, K | 1 |
| Inagaki, Y | 1 |
| Miyairi, M | 1 |
| Sugita, S | 2 |
| Iida, S | 1 |
| Tanabe, Y | 2 |
| Koike, S | 1 |
| Guhji, M | 1 |
| Ooi, T | 1 |
| Horie, Y | 1 |
| Inoue, J | 1 |
| Hara, Y | 1 |
| Okumura, M | 1 |
| Hirayama, C | 1 |
| Ogawa, N | 1 |
| Uehara, M | 1 |
| Saitoh, S | 1 |
| Takayama, H | 1 |
| Ojima, T | 1 |
| Iizuka, H | 1 |
| Katakai, S | 1 |
| Takezawa, J | 1 |
| Mavor, AI | 1 |
| Parkin, A | 1 |
| Riley, A | 1 |
| Smye, S | 1 |
| O'Brien, T | 1 |
| Robinson, PJ | 1 |
| Giles, GR | 1 |
| Ohtsuka, N | 1 |
| Nomoto, M | 1 |
| Ichida, T | 1 |
| Aoyagi, Y | 1 |
| Ichida, F | 1 |
| Shimizu, T | 3 |
| Sako, M | 3 |
| Hirota, S | 3 |
| Watanabe, H | 2 |
| Hasegawa, M | 2 |
| Hase, M | 2 |
| Kono, M | 1 |
| Sakamoto, K | 1 |
| Shimotsuma, M | 1 |
| Taniguchi, H | 1 |
| Sawai, K | 1 |
| Kagawa, K | 1 |
| Kamachi, M | 1 |
| Ashihara, T | 1 |
| Shimamura, Y | 1 |
| Itoh, Y | 1 |
| Saeki, T | 1 |
| Kuninobu, H | 1 |
| Kodama, H | 1 |
| Nishiyama, M | 1 |
| Yoshinaka, K | 1 |
| Toge, T | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Saitu, H | 1 |
| Nakayama, K | 1 |
| Tsuda, M | 1 |
| Nishioka, S | 1 |
| Yataka, I | 1 |
| Yoshikawa, T | 2 |
| Oyamada, H | 1 |
| Itani, K | 2 |
| Tainaka, K | 2 |
| Seto, O | 2 |
| Sugino, S | 2 |
| Kondo, M | 2 |
| Miyazone, K | 1 |
| Chang, T | 1 |
| Liu, WY | 1 |
| Kusumoto, T | 1 |
| Sato, S | 2 |
| Adachi, S | 1 |
| Todoroki, T | 1 |
| Ishikawa, A | 1 |
| Nosue, M | 1 |
| Fukao, K | 1 |
| Iwasaki, Y | 1 |
| Saida, Y | 1 |
| Doi, M | 1 |
| Ebisui, S | 1 |
| Maekawa, T | 1 |
| Mitoshi, M | 1 |
| Sasaki, T | 1 |
| Tarusawa, K | 1 |
| Midorikawa, H | 1 |
| Kanehira, J | 1 |
| Ikami, I | 1 |
| Yodono, H | 1 |
| Takekawa, SD | 1 |
| Nakamura, J | 1 |
| Nasu, H | 1 |
| Arakawa, H | 1 |
| Masamune, O | 1 |
| Al-Idrissi, HY | 1 |
| Ibrahim, EM | 1 |
| Abdel Satir, A | 1 |
| Satti, MB | 1 |
| Al-Kasem, S | 1 |
| Al-Qurain, A | 1 |
| Yoshioka, H | 1 |
| Wakasa, K | 1 |
| Iwai, M | 2 |
| Obata, H | 1 |
| Tomimatsu, M | 1 |
| Okazaki, N | 1 |
| Kim, K | 1 |
| Kurioka, N | 1 |
| Arai, Y | 1 |
| Ohyama, M | 1 |
| Ohtsuki, S | 1 |
| Naitoh, A | 1 |
| Tarumi, T | 1 |
| Nakase, A | 1 |
| Yagita, A | 1 |
| Watanabe, Y | 2 |
| Seki, M | 1 |
| Kitajima, M | 1 |
| Tachikawa, I | 1 |
| Onodera, H | 1 |
| Oikawa, M | 1 |
| Chida, N | 1 |
| Kimura, S | 2 |
| Goto, Y | 1 |
| Kondoh, H | 1 |
| Chin, JH | 1 |
| Oon, CJ | 1 |
| Tan, L | 1 |
| Yong, YM | 1 |
| Iwamura, F | 1 |
| Yamashita, Y | 1 |
| Shinzato, J | 1 |
| Saito, R | 1 |
| Korogi, Y | 1 |
| Sakai, M | 1 |
| Fujio, N | 1 |
| Hirohashi, K | 1 |
| Kubo, S | 1 |
| Iwasa, R | 1 |
| Naito, Y | 1 |
| Hotta, T | 1 |
| Ohmura, K | 1 |
| Matsuo, SK | 1 |
| Ohtsuka, Y | 1 |
| Hayasaka, A | 1 |
| Tsunoda, T | 1 |
| Nakada, H | 1 |
| Chin, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion Chemotherapy as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma(HCC): A Prospective Randomized Controlled Clinical Trial[NCT02767375] | Phase 2/Phase 3 | 192 participants (Anticipated) | Interventional | 2015-02-28 | Recruiting | ||
| A Prospective, Observational, Single-center Post-marketing Surveillance Study of Telbivudine in Chronic Hepatitis B Adults With HBeAg Positive/Negative.[NCT00970216] | 160 participants (Actual) | Observational | 2009-02-28 | Completed | |||
| Transarterial Chemoembolisation With Doxorubicin in Combination With Systemic Administration of Sorafenib for Patients With Hepatocellular Carcinoma[NCT00478374] | Phase 1 | 21 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| TACE Combined With Iodine-125 Seeds Implantation Versus TACE Alone for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective, Multicenter, Randomized, Controlled Study[NCT03322280] | 270 participants (Anticipated) | Interventional | 2018-07-01 | Active, not recruiting | |||
| The Clinical Randomized Trial of Adjuvant Transarterial Chemo Embolization (TACE) to Reduce the Recurrence in Hepatocellular Carcinoma (HCC) Patients at High Risk After Resection[NCT02788526] | Phase 3 | 180 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| A Humanitarian Device Exemption Use Protocol of Therasphere® for Treatment of Unresectable Hepatocellular and Metastatic Liver Tumors - HDE #980006[NCT00701168] | 0 participants | Expanded Access | No longer available | ||||
| A Randomized Phase II Trial of Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma or Who Are Unfit for Standard Therapy[NCT01097083] | Phase 2 | 20 participants | Interventional | 2010-04-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00970216)
Timeframe: 48 weeks
| Intervention | participants (Number) |
|---|---|
| Chronic Hepatitis B | 79 |
9 reviews available for mitomycin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Catheter-based transarterial therapies for hepatocellular cancer.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorub | 2015 |
Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Combine | 2003 |
[The chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cis | 2003 |
[Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gelatin Sponge, Ab | 2007 |
Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Reg | 1996 |
[Clinical effectiveness of degradable starch microspheres (DSM) in patients with liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1999 |
Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1999 |
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatoce | 1991 |
38 trials available for mitomycin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography.
Topics: Adult; Aged; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, Hepatocellula | 2013 |
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoc | 2014 |
Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepat | 2015 |
The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2008 |
Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 2010 |
Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.
Topics: Antineoplastic Agents; Antineoplastic Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cathe | 2010 |
Selective and sequential transarterial chemoembolization: survival in patients with hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Ethiodized Oil; Fe | 2012 |
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2011 |
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hep | 2012 |
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2013 |
Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2013 |
Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2002 |
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2003 |
Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
Topics: Adult; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antin | 2003 |
[Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Carboplatin | 2004 |
[Clinical observation on the treatment of middle-late stage liver carcinoma by combined therapy of hepato-arterial chemo-embolising and Chinese drugs for strengthening pi and regulating qi].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
[External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcin | 2005 |
[TACE: therapy of the HCC before liver transplantation--experiences].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Femal | 2005 |
Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2006 |
A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Catheterization; Dox | 1982 |
Targeted chemotherapy for unresectable primary and metastatic liver cancer.
Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; | 1994 |
[Primary hepatic carcinoma treated by chemoembolization--a clinical analysis of 20 cases with survival period longer than 3 years].
Topics: Adult; Aged; Carboplatin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Fe | 1994 |
Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, He | 1995 |
[Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuv | 1995 |
[Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 1994 |
[The treatment of hepatocellular carcinoma by chemoembolization].
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoe | 1994 |
Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Gelatin Spong | 1994 |
[The effect of high-dose intraarterial chemotherapy with percutaneous hepatic venous isolation and charcoal hemoperfusion (HVI.CHP) for unresectable multiple hepatocellular carcinoma--comparison with other therapeutic modalities].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Charcoal; Doxorubicin; Em | 1996 |
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studies; Che | 2000 |
[Phase I study of super high-dose chemotherapy for liver cancer with percutaneous isolated hepatic perfusion (PIHP) and peripheral blood stem cell transplantation (PBSCT)].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2000 |
Palliative treatment of hepatocellular carcinoma by chemoembolization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Cathet | 2001 |
Embolization and chemoembolization for hepatocellular carcinoma.
Topics: Capsules; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Hepa | 1992 |
Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1992 |
[Histologic assessment on resected hepatocellular carcinoma specimens with preoperative transcatheter hepatic arterial chemo-embolizations].
Topics: Adult; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arteri | 1991 |
[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
Topics: Administration, Oral; Biological Products; Carcinoma, Hepatocellular; Clinical Trials as Topic; Huma | 1988 |
[The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1988 |
327 other studies available for mitomycin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Taxane diterpenoids from the stem bark of Taxus mairei.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Humans; Magnetic Resonance Spectroscop | 2001 |
Germacrane-Type Sesquiterpenoids with Antiproliferative Activities from Eupatorium chinense.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2018 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Female; Huma | 2023 |
Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2020 |
Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tum | 2021 |
Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 2018 |
Outpatient Transarterial Chemoembolization of Hepatocellular Carcinoma: Review of a Same-Day Discharge Strategy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 2018 |
Gastrointestinal Elimination of a Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Ethiodized Oil; Humans; Live | 2018 |
Transarterial Chemoembolization (TACE) Using Mitomycin with or without Irinotecan for Hepatocellular Carcinoma in European Patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2018 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chol | 2019 |
Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2019 |
Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2013 |
Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2013 |
Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Topics: Analysis of Variance; Animals; Apoptosis; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2013 |
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2013 |
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; F | 2014 |
Long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion for multiple bilobar hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cance | 2014 |
Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2014 |
Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Asparagus Plant; Carcinoma, Hepatocellular; Caspase 3; | 2014 |
[Morphology and microRNA expression profiles of drug-resistant cells in hepatocellular carcinoma].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug R | 2013 |
[Analysis of the safety and efficacy of percutaneous isolated hepatic perfusion after particle therapy for advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cance | 2013 |
Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; | 2014 |
Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2014 |
Cutaneous necrosis associated with transcatheter arterial chemoembolization of the intercostal artery.
Topics: Adult; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatocellular; Collatera | 2014 |
A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma.
Topics: Acetylcholinesterase; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular | 2014 |
Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2015 |
Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells.
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Genomic Instability; Humans; Mice; Mitom | 2015 |
Precise Ratiometric Control of Dual Drugs through a Single Macromolecule for Combination Therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor | 2015 |
Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2016 |
Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Abl | 2016 |
Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
Topics: Animals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Ethio | 2016 |
Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Hepatocellular; Cholangitis; Cisplatin; Dose-Response Relati | 2009 |
Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Topics: Absorbable Implants; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carci | 2008 |
Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; | 2008 |
[Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2008 |
[Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
Topics: Adolescent; Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Diffusion M | 2008 |
RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2009 |
The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells.
Topics: Antineoplastic Agents; Antrodia; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2009 |
[Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
Topics: Adult; Aged; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modal | 2009 |
Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.
Topics: Bystander Effect; Carcinoma, Hepatocellular; Cell Count; Cell Death; Cell Line, Tumor; Cell Membrane | 2009 |
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Topics: Acrylic Resins; Adolescent; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antine | 2009 |
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; | 2010 |
[Evaluation of transhepatic artery chemotherapy for highly advanced hepatocellular carcinoma].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2010 |
Chemoembolic lobectomy: imaging findings of hepatic lobar volume reduction after transcatheter arterial chemoembolization.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Th | 2011 |
Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, | 2010 |
Hazardous chemical splatter during liver chemoembolization.
Topics: Accidents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolizat | 2010 |
[A case of Vp4 portal vein tumor thrombosis--a complete remission achieved with dual treatment of surgery plus percutaneous isolated hepatic perfusion].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusi | 2010 |
[Successful treatment of multiple pulmonary and peritoneal recurrence of hepatocellular carcinoma with bronchial artery infusion therapy and PEIT followed by surgery--a case report].
Topics: Aged, 80 and over; Antineoplastic Agents; Bronchial Arteries; Carcinoma, Hepatocellular; Ethanol; He | 2010 |
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin | 2011 |
Chemoembolization via branches from the splenic artery in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoembolization, Therape | 2012 |
Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; | 2011 |
Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studie | 2011 |
Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Res | 2011 |
Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ethiodized O | 2011 |
Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Su | 2012 |
Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheterizat | 2011 |
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carci | 2012 |
Retrospective study on the use of different protocols for repeated transarterial chemoembolization in the treatment of patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2012 |
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2012 |
Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Cisplatin; Contras | 2012 |
Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization | 2012 |
Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Epirubicin; Ethiodized O | 2012 |
Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2012 |
Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?
Topics: Antibiotic Prophylaxis; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therape | 2012 |
Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Enbucrila | 2012 |
Dual-phase CT angiography through the port-catheter system for hepatic arterial infusion chemotherapy using multislice CT: assessment of system dysfunction and impact on predicting clinical problems.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Carcinoma, Hepatoc | 2012 |
Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Case-Control Studie | 2013 |
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Down-Reg | 2013 |
[A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Humans; Iodized Oil; Li | 2002 |
Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2003 |
Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2001 |
[Synergistic antitumor effect of sodium caffeate and mitomycin].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Caffeic Acids; Calcium; Carcinoma, Hepa | 2002 |
Synergistic effects of geldanamycin and antitumor drugs.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; | 2001 |
Liver metastasis of pancreatic cancer managed by intra-arterial infusion chemotherapy combined with degradable starch microspheres.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Carcinoma, Hepatocellular; Chemo | 2003 |
Long-term survival of Taiwanese patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; | 2003 |
ADMINISTRATION METHOD OF MITOMYCIN C.
Topics: Carcinoma, Hepatocellular; Liver Neoplasms; Methylcholanthrene; Mitomycin; Mitomycins; Neoplasms; Ne | 1964 |
PAPER ELECTROPHORETIC STUDIES ON SERUM PROTEINS IN THE DISEASES OF THE DIGESTIVE SYSTEM, WITH PARTICULAR REFERENCE TO THE CHANGES IN SERUM PROTEINS IN THE PATIENTS WITH CANCER.
Topics: Antineoplastic Agents; Blood Protein Electrophoresis; Blood Proteins; Carcinoma, Hepatocellular; Dig | 1963 |
INHIBITORY EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS ON LIVER METASTASIS OF INTRAPORTALLY INOCULATED MOUSE ASCITES HEPATOMA.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Injection | 1964 |
THE USE OF RAT ASCITES TUMORS HETEROGRAFTED IN MICE FOR SCREENING OF ANTICANCEROUS AGENTS.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Carcinoma, Ehrlich Tumor; Carcinoma, | 1963 |
[EXPERIMENTAL STUDIES ON THE EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS TO LIVER METASTASIS FOLLOWING PORTAL INJECTION OF MOUSE ASCITES HEPATOMA].
Topics: Animals; Ascites; Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Mice; Mitomycin; Mitom | 1963 |
[DEVELOPMENT OF FREE-CELL SUBLINES OF THE ASCITES HEPATOMA AH-130 AND THEIR BIOLOGICAL PROPERTIES].
Topics: Ascites; Carcinoma, Hepatocellular; Chromosomes; Electrons; Liver Neoplasms; Mechlorethamine; Micros | 1964 |
[EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Leukemia; Leuke | 1964 |
Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Pe | 2003 |
Multimodality management of hepatocellular carcinoma larger than 10 cm.
Topics: Acetic Acid; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2003 |
[Screening of the drug resistance-associated gene in HepG2 cell line transfected with aldose reductase like gene-1 (ARL-1)].
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; ATP Binding Cassette Transporter, S | 2003 |
[Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2004 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Topics: Adrenal Glands; Aged; Antibiotics, Antineoplastic; Arteries; Carcinoma, Hepatocellular; Catheters, I | 2004 |
2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; | 2004 |
Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Topics: Albumins; Antibiotics, Antineoplastic; Antineoplastic Agents; Bilirubin; Carcinoma, Hepatocellular; | 2004 |
[Hepatic arterial infusion and occlusion technique for the evaluation of the hepatic resection to control the local liver tumor].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2004 |
[The value of Roferon-A combined with hepatic artery chemoembolization and portal vein chemotherapy after radical resection in hepatocellular carcinoma for preventing recurrence].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combi | 2004 |
[Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; | 2004 |
[A case of diffuse type of hepatocellular carcinoma with tumor thrombosis of inferior vena cava (Vv3) and main trunk of portal vein (Vp4), showing marked response to transcatheter arterial chemoembolization with degradable starch microspheres (DSM-TACE)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
[Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; | 2005 |
Intraarterial chemotherapy: another choice for unresectable advanced hepatocellular carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 2004 |
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Adm | 2004 |
[A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-u
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 2005 |
[Low-output radiofrequency ablation combined with transcatheter arterial oily-chemoembolization for hepatocellular carcinoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoemboliz | 2005 |
[Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2005 |
Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2006 |
[Observation on efficiency of shelian capsule as adjuvant of embolismic chemotherapy on primary hepatic carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoco | 2005 |
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ch | 2005 |
[Investigation of bile duct injury after transcatheter arterial chemoembolization].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts; Carcinom | 2005 |
O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.
Topics: Animals; Antibiotics, Antineoplastic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tu | 2006 |
Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carcinoma, H | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, | 2007 |
MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Topics: Butadienes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; | 2007 |
Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Topics: Animals; Antineoplastic Agents; Azacitidine; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor | 2007 |
Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Disease | 2007 |
Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Li | 2007 |
[Effect of constitutive androstane receptor on the cytotoxicity of mitomycin C and 5-(aziridin-1-yl)-3-hydroxymethyl-1-methylindole-4,7-dione].
Topics: Antibiotics, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Aziridines; Carcinoma, Hepatocellular; C | 2007 |
RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Topics: Adult; Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor | 2008 |
[Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cause of Death; Chemoembolization, The | 2007 |
Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-alpha signalling.
Topics: Apoptosis; Base Sequence; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Cell Line, Tumor; Drug Sy | 2007 |
[Expression of survivin mRNA and protein in mitomycin-treated hepatoma carcinoma Hepa1-6 cells].
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Inhibit | 2008 |
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Contrast Media; Doxorubi | 2008 |
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
Hepatitis B virus X protein disrupts DNA interstrand crosslinking agent mitomycin C induced ATR dependent intra-S-phase checkpoint.
Topics: Carcinoma, Hepatocellular; Checkpoint Kinase 1; DNA Damage; Hepatitis B, Chronic; Humans; Liver Neop | 2008 |
[MMC-oil suspension (MOS) as a new chemoembolic agent].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hum | 1984 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; C | 1984 |
[Effects of arterial chemotherapy in patients with hepatocellular carcinoma--alternate administration of mitomycin C and adriamycin].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Female; Hepatic Artery; Humans; | 1984 |
Evaluation of conservative therapeutic modalities for hepatocellular carcinoma--analysis of 206 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1984 |
Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1983 |
[Treatment of hepatocellular carcinoma with one-shot arterial infusion of mitomycin C].
Topics: Adult; Aged; alpha-Fetoproteins; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular | 1982 |
[Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluor | 1982 |
Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumors.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Doxorubicin; Hepatic Artery; Humans; Ligation; Liv | 1983 |
Continuous intra-arterial infusion chemotherapy of hepatoma.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Fema | 1983 |
[Chemo-embolization with mitomycin C microcapsules for hepatoma].
Topics: alpha-Fetoproteins; Capsules; Carcinoma, Hepatocellular; Catheterization; Embolization, Therapeutic; | 1984 |
[Balloon occluded arterial infusion therapy for malignant hepatic tumors].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Doxorub | 1984 |
Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules.
Topics: Adult; Aged; alpha-Fetoproteins; Angiography; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular | 1984 |
[Transcatheter hepatic artery embolization in 60 patients with hepatocellular carcinoma studies on angiographic features (author's transl)].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Child; Child, Preschool; Doxorubicin; Embolizati | 1981 |
[Liver diseases. C 1. Treatment of liver cancer].
Topics: Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycin | 1982 |
[Clinical efficacy of transcatheter arterial embolization in hepatocellular carcinoma--evaluation in comparison with hepatic artery infusion chemotherapy].
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neopl | 1983 |
[Treatment of unresectable hepatocellular carcinoma by arterial infusion of mitomycin C microcapsules (MMCmc)].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasm | 1983 |
[Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer].
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Capsules; Carcinoma, Hepatocellular; Hepatic Artery; | 1983 |
[Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
Topics: Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Therapy, Combination; Female; Fl | 1982 |
[Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Drug Therapy, Combination; Female; Hepatic Arte | 1982 |
[Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Colonic Neoplasms; Drug Synergism; Dru | 1983 |
Total tumor cell count and hematopoietic system of ah 109A-bearing rats treated with mitomycin C and carboquone.
Topics: Animals; Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Hepatocellular; Cell Transform | 1982 |
[Preoperative chemo-embolization for liver cell cancer].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Embolization, Therap | 1983 |
Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined C | 1994 |
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Carcinoma, Hepatocellular; Catheterization, Peripheral; | 1994 |
Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth.
Topics: Animals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Division; Chemotherapy, Adjuvant; Cholestero | 1995 |
Pancreatic tissue damage by transcatheter arterial embolization for hepatoma.
Topics: Adult; Aged; Amylases; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Gelatin Sponge, | 1993 |
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Ethanol; Femal | 1993 |
[Palliative therapy of primary liver tumors].
Topics: Adenoma, Bile Duct; Adolescent; Adult; Aged; alpha-Fetoproteins; Angiography; Antineoplastic Combine | 1993 |
The anticlastogenicity of beta-carotene evaluated on human hepatoma cells.
Topics: beta Carotene; Carcinoma, Hepatocellular; Carotenoids; Cyclophosphamide; Humans; Micronucleus Tests; | 1993 |
Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters.
Topics: Apoptosis; Carcinogens; Carcinoma, Hepatocellular; DNA Damage; Etoposide; Flow Cytometry; Humans; Ly | 1995 |
Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzofurans; Biological Transport; Carc | 1995 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterizat | 1995 |
[Noradrenaline-assisted selective chemoembolization of hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Femal | 1994 |
[Targeting treatment of human HCC xenografts implanted in nude mice using bifunctional antibody HC-1 combined with mitomycin C].
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoma, Hepatocellular; Humans; Immunoto | 1994 |
[Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 1994 |
[Survival in 46 patients with hepatocarcinoma treated by chemoembolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; Humans; Liv | 1994 |
Multiple intrahepatic aneurysms following transcatheter arterial embolization. Work in progress.
Topics: Aneurysm; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Gelatin Sponge, Absorba | 1994 |
[A case of poorly differentiated hepatic cell carcinoma which showed 90% decrease in size after chemotherapy with intraarterial infusion of mitomycin C and oral administration of tegafur].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Glutamine; Intestinal Mucosa; Leucine; Li | 1994 |
[Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for nodular type of hepatocellular carcinoma non-occluding the main portal vein--in comparison with transcatheter arterial embolization].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Emboli | 1994 |
Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 1994 |
Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1994 |
Effective cases of transcatheter arterioportal chemoembolization with high-dose iodized oil for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
[Application of crossed assay design in test of drug sensitivity in vitro in combined chemotherapy of liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1993 |
Splenic arterial portal infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Do | 1994 |
[A case of icteric type hepatoma responding to MMC infusion therapy via cannulation into the hepatic artery].
Topics: Aged; Carcinoma, Hepatocellular; Cholestasis; Female; Humans; Infusions, Intra-Arterial; Liver Neopl | 1993 |
Diagnosis and therapy for primary hepatic carcinoma: transcatheter inferior phrenic arteriography and chemoembolization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1993 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1993 |
[Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1993 |
Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1993 |
[Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization (TAE)--significance of repetitive therapies and responses to them within 6 months after the first intervention].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 1993 |
[Treatment of hepatocellular carcinoma by transarterial approach].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1993 |
[Transcatheter hepatic segmental chemo-Lipiodol-embolization against hepatocellular carcinoma accompanied by tumor thrombosis in the portal vein].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized | 1993 |
Superselective intra-arterial chemotherapy with mitomycin C in hepatic neoplasms.
Topics: Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Gallbladder Neoplasms; Hepatic Artery | 1993 |
[Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1993 |
[Complication of gastro-duodenum with intra-hepatic arterial infusion chemotherapy using implantable reservoir system for hepatic tumors].
Topics: Carcinoma, Hepatocellular; Cisplatin; Drug Administration Schedule; Duodenal Diseases; Female; Fluor | 1993 |
[A new mode of expression for the assessment of capacities of DNA repair by flow cytometry].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Division; Depression, Chemical; DNA Rep | 1995 |
Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Topics: Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Case-Control Studi | 1995 |
Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Topics: Alternative Splicing; Antibiotics, Antineoplastic; Base Sequence; Carcinoma, Hepatocellular; Cell Li | 1996 |
[Mitomycin C-DNA adduct detection in rat organs and human liver].
Topics: Adult; Animals; Carcinoma, Hepatocellular; DNA Adducts; Female; Humans; Liver; Liver Cirrhosis; Live | 1996 |
Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Carcinoma, Hepatocellula | 1996 |
Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Carrier Proteins; Cisplatin; Doxorubicin; D | 1996 |
Arteritis following intra-arterial chemotherapy for liver tumors.
Topics: Aged; Antibiotics, Antineoplastic; Arteritis; Carcinoma, Hepatocellular; Chemoembolization, Therapeu | 1997 |
Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival.
Topics: Animals; Antineoplastic Agents; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hep | 1997 |
[Percutaneous transcatheter thermotherapy (PTCT): use of hotwire for local tumor control].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1997 |
[Antibody-targeted radio-chemotherapy of human primary liver cancer with radio-iodinated AFP monoclonal antibodies conjugated with mitomycin C: a preliminary clinical observation].
Topics: Adult; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoma, Hepatocel | 1996 |
Intraarterial infusion of dibutyryl cyclic adenosine monophosphate plus mitomycin C for unresectable hepatocellular carcinoma: long-term survival and response to tumor growth inhibition.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, | 1995 |
[Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1998 |
Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, | 1997 |
Comparison of HepG2 feeder cells generated by exposure to gamma-rays, X-rays, UV-C light or mitomycin C for ability to activate 7,12-dimethylbenz[a]anthracene in a cell-mediated Chinese hamster V79/HGPRT mutation assay.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Biotransformation; Carcinoma, Hepatocellular; Coculture T | 1999 |
Effects of doxorubicin, mitomycin C, and ethanol on Hep-G2 cells in vitro.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Count; | 1999 |
Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents; Car | 1999 |
Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population.
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 1999 |
Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellu | 1999 |
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein.
Topics: Aclarubicin; Aged; Antibiotics, Antineoplastic; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Che | 1999 |
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepat | 2000 |
Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Dendritic Ce | 2000 |
Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cell Survival; Cytoprotection; Doxorubicin; Endoth | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 2000 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatoc | 2000 |
Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transport | 2001 |
Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Car | 2001 |
Chemoembolization as a bridge to transplantation for hepatocellular carcinoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Th | 2001 |
[Transarterial chemoembolization in hepatocellular carcinomas: technique, indications, results].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diagnosti | 2001 |
An antisense construct of full-length human RAD50 cDNA confers sensitivity to ionizing radiation and alkylating agents on human cell lines.
Topics: Acid Anhydride Hydrolases; Alkylating Agents; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; C | 2002 |
[Intervention treatment of hepatocellular carcinoma with 125I-lipiodol plus chemotherapeutic drugs and self body hairs: a report of 56 cases].
Topics: Adult; Aged; Agmatine; alpha-Fetoproteins; Arteries; Carcinoma, Hepatocellular; Chemoembolization, T | 2000 |
Chemoembolization for primary liver cancer.
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; | 2002 |
[Gastroduodenal ulcer, perforation after chemo-embolization in 4 cases of advanced hepatocellular carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1999 |
Is necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; | 1992 |
[Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Doxoru | 1992 |
Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Colorectal Neoplasms; Female; Fluorouraci | 1992 |
[Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS)].
Topics: Adenoma, Bile Duct; Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubi | 1992 |
[A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Epirubicin; Hepatic Arter | 1992 |
[Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Evaluation Studies as | 1992 |
Hepatocellular carcinoma and transcatheter oily chemoembolization in Thailand.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Gelatin | 1992 |
The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions.
Topics: Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cell Hypoxia; Cisplatin; Doxorubi | 1992 |
[Effects of intra-arterial infusion chemotherapy with radiation therapy for advanced hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1992 |
[Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; F | 1992 |
[Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therap | 1992 |
[Intermittent intra-arterial chemotherapy using subcutaneously implanted reservoir for hepatocellular carcinoma and liver metastasis of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1992 |
[Disappearance of lung metastases from hepatocellular carcinoma following bronchial arterial infusion of CDDP and MMC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Hepatocellular; Cispl | 1992 |
[Stage III, IV hepatocellular carcinoma patients surviving more than five years after transcatheter chemoembolization].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Humans; Iodized Oil; L | 1992 |
[Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using implantable drug delivery system].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubic | 1992 |
[Clinical evaluation of operative and non-operative treatment in hepatocellular carcinoma with main portal vein tumor thrombus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 1992 |
[Hepatic carcinoma treated by hepatic arterial embolization using 131I and chemotherapeutic agent gelatin microspheres: report of 9 cases].
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Gelatin; Hepatic Artery; Hum | 1992 |
[The efficacy of transcatheter arterial infusion chemotherapy in patients with hepatocellular carcinoma].
Topics: Administration, Oral; Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Doxorubicin; Femal | 1992 |
[A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1991 |
[Efficacy of anticancer agent-lipiodol emulsion for hepatic arterial infusion and regional hyperthermia in patients with nonresectable hepatoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modal | 1991 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; D | 1991 |
[Effects of intraarterial infusion chemotherapy on liver function in patients with hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cytarabine; | 1991 |
[Effectiveness and timing of one shot transarterial infusion and/or transcatheter arterial embolization therapy for recurrence of postoperative hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeuti | 1991 |
[Transcatheter hepatic artery infusion chemotherapy and embolization for 60 patients with primary hepatic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 1991 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1991 |
[Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization].
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Hepatic Artery; Humans; In | 1991 |
[Balloon occluded arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Doxorubi | 1991 |
Hepatocellular carcinoma associated with polyarteritis nodosa with symptoms appearing after intra-arterial chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Hepatic Artery; Humans; Injections, I | 1991 |
[The changes in tumor marker levels after chemolipiodolization in early phase].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryo | 1991 |
Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Drug Screening Assays, Antitumo | 1991 |
Prevention of gastric complications in hepatic arterial chemoembolization. Balloon catheter occlusion technique.
Topics: Carcinoma, Hepatocellular; Catheterization; Doxorubicin; Embolization, Therapeutic; Gelatin Sponge, | 1991 |
Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Ge | 1991 |
[Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1991 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1990 |
[Combined therapy for unresectable hepatocellular carcinoma with hepatic arterial infusion of lymphokine-activated killer cells from autologous splenocytes and of lipiodolized antitumor agent].
Topics: Carcinoma, Hepatocellular; Hepatic Artery; Humans; Immunization, Passive; Infusions, Intra-Arterial; | 1990 |
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Delayed-Action Preparations; Embolizatio | 1990 |
[Evaluation of the efficacy of oil chemoembolization for hepatocellular carcinoma by computed tomography: a proposal for altering the criteria to indicate the efficacy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Female; H | 1990 |
[Evaluation of quality of life in arterial infusion chemotherapy of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Hepatic Artery; Hospitalization; | 1990 |
[Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1990 |
[Intermittent arterial chemoembolization in liver tumor using degradable starch microspheres].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Humans; Infu | 1990 |
[Therapeutic effects by implantable infusion pump for hepatic malignant tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorub | 1990 |
[Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile | 1990 |
[Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy].
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Ne | 1990 |
[A case of hepatocellular carcinoma treated by intrahepatic arterial administration of anticancer agents: serial determination of the concentration of the chemotherapeutic agents in serum and dialysate during hemodialysis].
Topics: Adult; Carcinoma, Hepatocellular; Doxorubicin; Hepatic Artery; Humans; Infusions, Intra-Arterial; In | 1990 |
[Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Hepatocellular; Combined | 1985 |
Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
Topics: Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biodegradation, Env | 1985 |
[A case of hepatocellular carcinoma treated by irradiation after ADMOS (adriamycin/mitomycin C-oil suspension) arterial infusion therapy].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular | 1986 |
[Transcatheter hepatic arterial chemoembolization using microencapsulated mitomycin C (MMCmc)].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Compounding; Embolization, Therapeu | 1988 |
Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Electron Probe Microanalysis; Embolization, Therapeut | 1988 |
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cisp | 1989 |
[The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1989 |
Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma.
Topics: Aclarubicin; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1989 |
[Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children].
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocel | 1989 |
Transcatheter arterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Ther | 1989 |
Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Therapeutic; Hepa | 1989 |
Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Catheterization, Peripheral; Doxorubicin; Embolization, Therapeutic; Hepa | 1989 |
High-dose mitomycin C: activity in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Evaluation; Female; Human | 1989 |
[Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Combined Modality Therapy; Doxorubicin; | 1989 |
[Influence of hepatic ischemia on liver regeneration following hepatectomy, with special reference to the therapeutic choice for ruptured hepatoma].
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Isc | 1989 |
[An assessment of therapeutic effects by transcatheter arterial embolization (TAE) with degradable starch microspheres (DSM) for hepatic malignant tumors].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 1989 |
[New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality T | 1989 |
[Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Colorectal Neoplasms; Com | 1989 |
[Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Drug E | 1989 |
[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Combin | 1989 |
[A case of recurrent hepatocellular carcinoma successfully treated by arterial chemoembolization in combination with local hyperthermia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 1989 |
[Analysis of prognostic factors in patients with hepatocellular cancer treated by hepatic arterial infusion chemotherapy].
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1989 |
[Assessment of three-year survival cases with unresectable hepatocellular carcinoma treated by arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1989 |
[Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Female; Hepa | 1989 |
Arterial infusion of combination therapy using dibutyryl adenosine 3',5'-monophosphate and mitomycin C for hepatocellular carcinoma occluding main portal vein: case studies.
Topics: Adult; Aged; Bucladesine; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Humans; Infu | 1989 |
Chemoembolization of liver malignancies--the experience at the university-hospital in Frankfurt/M. (West-Germany).
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; | 1989 |
[A resected case of hepatocellular carcinoma effectively treated by hepatic artery embolization and systemic chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modal | 1989 |
[Two cases of digestive cancer demonstrated remarkable regression by hyperthermia with systemic chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Colonic N | 1989 |
[Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic | 1989 |
Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma.
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Catheterization; Embolization, Therapeutic; Female; Hepat | 1987 |
[Combination intra-arterial chemotherapy with degradable starch microspheres and mitomycin C against inoperable hepatic metastases].
Topics: Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microsp | 1988 |
[Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Emulsions; Humans | 1988 |
Initial clinical experience with degradable starch microspheres.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female | 1987 |
[Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Furans; Hepatecto | 1988 |
Clinical evaluation of transcatheter arterial embolization and one-shot chemotherapy in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; | 1988 |
[Clinical evaluation of advanced hepatocellular carcinomas with intraarterial infusion therapy using polysaccharide solution as a carrier of anticancer drugs].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Evaluation Studies as Topic; Humans; Infusions, Intra-Arteri | 1988 |
[Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; DNA; Doxorubicin; Embolization, Therapeut | 1988 |
[Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; D | 1988 |
[Hepatic arterial infusion chemotherapy and hyperthermia with degradable starch microspheres in primary and metastatic liver malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Combin | 1988 |
[Multidisciplinary treatment of unresectable liver cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Mod | 1988 |
[Treatment with degradable starch microspheres (DSM) in malignant hepatic tumors-clinical experience of implantable drug delivery system (Port-A-Cath)].
Topics: Adenoma, Bile Duct; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carci | 1988 |
[Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1988 |
[Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].
Topics: Adenoma, Bile Duct; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Doxorubicin; Embolization, | 1988 |
[Chemo-embolization of primary hepatocellular carcinoma].
Topics: Adult; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Hu | 1987 |
Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cisplatin; Doxorubic | 1988 |
Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis.
Topics: Animals; Carcinoma, Hepatocellular; DNA; DNA Damage; DNA, Neoplasm; Humans; Leukocytes; Liver Neopla | 1988 |
[Transcatheter arterial infusion therapy using lipiodol and mitomycin C for hepatocellular carcinoma with liver cirrhosis].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Humans; Infusions, Intr | 1988 |
[A case of HCC with a tumor thrombus in the main portal vein surviving (Vp4) for over three years and six months].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubi | 1988 |
[Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect].
Topics: Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Humans; Iodized Oil; L | 1988 |
[A case of hepatocellular carcinoma surviving more than five years by chemoembolization with mitomycin C microcapsules].
Topics: Aged; Capsules; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; | 1988 |
[Intra-arterial infusion therapy with polysaccharide solution as a carrier of anticancer agents--a new method of intra-arterial infusion therapy].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Delayed-Action P | 1988 |
Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1985 |
[Preoperative chemo-embolization for treatment of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Humans; Iodized Oil; Liver | 1985 |
[Retrospective study of short survival cases in hepatocellular carcinoma after transcatheter arterial embolization therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Human | 1985 |
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; | 1985 |
[Alteration of blood coagulation and fibrinolysis after transcatheter arterial embolization of hepatocellular carcinomas].
Topics: Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Carcinoma, Hepatocellular; Doxo | 1985 |
[Study of 45 patients with hepatocellular carcinoma complicating occlusion of the main portal vein].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; L | 1985 |
[Low-dose intermittent intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dox | 1985 |
[One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1985 |
[Transarterial chemoembolization therapy of hepatocellular carcinoma using anticancer agents (mitomycin C and/or adriamycin) suspended in lipiodol].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1985 |
[Intraarterial infusion therapy with polysaccharide solution as a carrier of anticancer drugs].
Topics: Animals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Dogs; Humans; Infusions, Intra-Arte | 1985 |
[Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
Topics: Adult; Biological Products; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Femal | 1986 |
[Evaluation of intermittent hepatic arterial occlusion with infusion chemotherapy of unresectable hepatocellular carcinoma].
Topics: Aged; Animals; Carcinoma, Hepatocellular; Dogs; Embolization, Therapeutic; Female; Fluorouracil; Hep | 1986 |
[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neopl | 1986 |
[Large amount of intra-arterial injection of iodized oil (Lipiodol) in the treatment of unresectable hepatoma].
Topics: Aged; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Hum | 1986 |
Emphysematous cholecystitis: complication of hepatic artery embolization.
Topics: Aged; Carcinoma, Hepatocellular; Cholecystitis; Embolization, Therapeutic; Emphysema; Gelatin Sponge | 1986 |
Treatment of irresectible hepatocellular carcinoma with intrahepatic arterial lipoidal mixed with adriamycin and mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; | 1986 |
[A case of hepatoma effectively treated by TAE and intra-arterial and intraportal infusion chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 1986 |
[Ruptured hepatocellular carcinoma following transcatheter arterial embolization: a case report].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Hepatic Arte | 1986 |
[Chemotherapy of balloon-occluded arterial infusion in a patient with unresectable hepatocellular carcinoma and autoimmune hemolytic anemia].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepa | 1986 |
[Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization | 1987 |
[Chemoembolization with degradable starch microspheres in malignant hepatic tumors].
Topics: Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial | 1987 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Adminis | 1987 |
[Comparison of various therapeutic modalities with transcatheter arterial infusion of anticancer drugs in hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization | 1986 |
[Intra-arterial chemoembolization with albumin microspheres including mitomycin C in inoperable hepatic cancer].
Topics: Adult; Aged; Albumins; Animals; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Infusions | 1987 |